<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2d1 20170631//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="article" dtd-version="1.2d1" specific-use="production" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">BIORXIV</journal-id>
<journal-title-group>
<journal-title>bioRxiv</journal-title>
<abbrev-journal-title abbrev-type="publisher">bioRxiv</abbrev-journal-title>
</journal-title-group>
<publisher>
<publisher-name>Cold Spring Harbor Laboratory</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1101/286617</article-id>
<article-version>1.1</article-version>
<article-categories>
<subj-group subj-group-type="author-type">
<subject>Regular Article</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>New Results</subject>
</subj-group>
<subj-group subj-group-type="hwp-journal-coll">
<subject>Genetics</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Low frequency and rare coding variation contributes to multiple sclerosis risk</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<collab>International Multiple Sclerosis Genetics Consortium</collab>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mitrovic</surname>
<given-names>Mitja</given-names>
</name>
<xref ref-type="aff" rid="a2">2</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-3757-8941</contrib-id>
<name>
<surname>Patsopoulos</surname>
<given-names>Nikolaos</given-names>
</name>
<xref ref-type="aff" rid="a3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Beecham</surname>
<given-names>Ashley</given-names>
</name>
<xref ref-type="aff" rid="a4">4</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1315-9454</contrib-id>
<name>
<surname>Dankowski</surname>
<given-names>Theresa</given-names>
</name>
<xref ref-type="aff" rid="a5">5</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1276-6682</contrib-id>
<name>
<surname>Goris</surname>
<given-names>An</given-names>
</name>
<xref ref-type="aff" rid="a6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Dubois</surname>
<given-names>Benedicte</given-names>
</name>
<xref ref-type="aff" rid="a6">6</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0917-4176</contrib-id>
<name>
<surname>Dhooghe</surname>
<given-names>Marie-Beatrice</given-names>
</name>
<xref ref-type="aff" rid="a7">7</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-4948-5956</contrib-id>
<name>
<surname>Lemmens</surname>
<given-names>Robin</given-names>
</name>
<xref ref-type="aff" rid="a6">6</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-6384-0611</contrib-id>
<name>
<surname>Van Damme</surname>
<given-names>Philip</given-names>
</name>
<xref ref-type="aff" rid="a6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Fitzgerald</surname>
<given-names>Kate</given-names>
</name>
<xref ref-type="aff" rid="a8">8</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bach Sondergaard</surname>
<given-names>Helle</given-names>
</name>
<xref ref-type="aff" rid="a9">9</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1333-9623</contrib-id>
<name>
<surname>Sellebjerg</surname>
<given-names>Finn</given-names>
</name>
<xref ref-type="aff" rid="a9">9</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-2818-3780</contrib-id>
<name>
<surname>Sorensen</surname>
<given-names>Per Soelberg</given-names>
</name>
<xref ref-type="aff" rid="a9">9</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ullum</surname>
<given-names>Henrik</given-names>
</name>
<xref ref-type="aff" rid="a10">10</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-4391-4956</contrib-id>
<name>
<surname>Wegner Thoerner</surname>
<given-names>Lise</given-names>
</name>
<xref ref-type="aff" rid="a11">11</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-1829-0766</contrib-id>
<name>
<surname>Werge</surname>
<given-names>Thomas</given-names>
</name>
<xref ref-type="aff" rid="a12">12</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Saarela</surname>
<given-names>Janna</given-names>
</name>
<xref ref-type="aff" rid="a13">13</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-9400-0970</contrib-id>
<name>
<surname>Cournu-Rebeix</surname>
<given-names>Isabelle</given-names>
</name>
<xref ref-type="aff" rid="a14">14</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-7321-8575</contrib-id>
<name>
<surname>Damotte</surname>
<given-names>Vincent</given-names>
</name>
<xref ref-type="aff" rid="a14">14</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Fontaine</surname>
<given-names>Bertrand</given-names>
</name>
<xref ref-type="aff" rid="a14">14</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Guillot-Noel</surname>
<given-names>Lena</given-names>
</name>
<xref ref-type="aff" rid="a14">14</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lathrop</surname>
<given-names>Mark</given-names>
</name>
<xref ref-type="aff" rid="a15">15</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Vukusik</surname>
<given-names>Sandra</given-names>
</name>
<xref ref-type="aff" rid="a16">16</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-1131-9554</contrib-id>
<name>
<surname>Gourraud</surname>
<given-names>Pierre-Antoine</given-names>
</name>
<xref ref-type="aff" rid="a17">17</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-2917-5889</contrib-id>
<name>
<surname>Andlauer</surname>
<given-names>Till</given-names>
</name>
<xref ref-type="aff" rid="a18">18</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pongratz</surname>
<given-names>Viola</given-names>
</name>
<xref ref-type="aff" rid="a19">19</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Buck</surname>
<given-names>Dorothea</given-names>
</name>
<xref ref-type="aff" rid="a19">19</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0524-6005</contrib-id>
<name>
<surname>Gasperi</surname>
<given-names>Christiane</given-names>
</name>
<xref ref-type="aff" rid="a19">19</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-6647-7889</contrib-id>
<name>
<surname>Graetz</surname>
<given-names>Christiane</given-names>
</name>
<xref ref-type="aff" rid="a20">20</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bayas</surname>
<given-names>Antonios</given-names>
</name>
<xref ref-type="aff" rid="a21">21</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-8131-9467</contrib-id>
<name>
<surname>Heesen</surname>
<given-names>Christoph</given-names>
</name>
<xref ref-type="aff" rid="a22">22</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kumpfel</surname>
<given-names>Tania</given-names>
</name>
<xref ref-type="aff" rid="a23">23</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-9775-3719</contrib-id>
<name>
<surname>Linker</surname>
<given-names>Ralf</given-names>
</name>
<xref ref-type="aff" rid="a24">24</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Paul</surname>
<given-names>Friedemann</given-names>
</name>
<xref ref-type="aff" rid="a25">25</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-2504-5398</contrib-id>
<name>
<surname>Stangel</surname>
<given-names>Martin</given-names>
</name>
<xref ref-type="aff" rid="a26">26</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tackenberg</surname>
<given-names>Bjorn</given-names>
</name>
<xref ref-type="aff" rid="a27">27</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Then Bergh</surname>
<given-names>Florian</given-names>
</name>
<xref ref-type="aff" rid="a28">28</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Warnke</surname>
<given-names>Clemens</given-names>
</name>
<xref ref-type="aff" rid="a29">29</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-5509-1075</contrib-id>
<name>
<surname>Wiendl</surname>
<given-names>Heinz</given-names>
</name>
<xref ref-type="aff" rid="a30">30</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wildemann</surname>
<given-names>Brigitte</given-names>
</name>
<xref ref-type="aff" rid="a31">31</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zettl</surname>
<given-names>Uwe</given-names>
</name>
<xref ref-type="aff" rid="a32">32</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ziemann</surname>
<given-names>Ulf</given-names>
</name>
<xref ref-type="aff" rid="a33">33</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-7921-9966</contrib-id>
<name>
<surname>Tumani</surname>
<given-names>Hayrettin</given-names>
</name>
<xref ref-type="aff" rid="a34">34</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gold</surname>
<given-names>Ralf</given-names>
</name>
<xref ref-type="aff" rid="a35">35</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Grummel</surname>
<given-names>Verena</given-names>
</name>
<xref ref-type="aff" rid="a19">19</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-5985-6784</contrib-id>
<name>
<surname>Hemmer</surname>
<given-names>Bernhard</given-names>
</name>
<xref ref-type="aff" rid="a19">19</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-4187-9472</contrib-id>
<name>
<surname>Knier</surname>
<given-names>Benjamin</given-names>
</name>
<xref ref-type="aff" rid="a19">19</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1903-6762</contrib-id>
<name>
<surname>Lill</surname>
<given-names>Christina</given-names>
</name>
<xref ref-type="aff" rid="a36">36</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Luessi</surname>
<given-names>Efthimios</given-names>
</name>
<xref ref-type="aff" rid="a36">36</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1862-7499</contrib-id>
<name>
<surname>Dardiotis</surname>
<given-names>Efthimios</given-names>
</name>
<xref ref-type="aff" rid="a37">37</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-2022-3386</contrib-id>
<name>
<surname>Agliardi</surname>
<given-names>Cristina</given-names>
</name>
<xref ref-type="aff" rid="a38">38</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-2090-5638</contrib-id>
<name>
<surname>Barizzone</surname>
<given-names>Nadia</given-names>
</name>
<xref ref-type="aff" rid="a39">39</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mascia</surname>
<given-names>Elisabetta</given-names>
</name>
<xref ref-type="aff" rid="a40">40</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-7551-6664</contrib-id>
<name>
<surname>Bernardinelli</surname>
<given-names>Luisa</given-names>
</name>
<xref ref-type="aff" rid="a41">41</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-6989-1054</contrib-id>
<name>
<surname>Comi</surname>
<given-names>Giancarlo</given-names>
</name>
<xref ref-type="aff" rid="a40">40</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1006-7597</contrib-id>
<name>
<surname>Cusi</surname>
<given-names>Daniele</given-names>
</name>
<xref ref-type="aff" rid="a42">42</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Esposito</surname>
<given-names>Federica</given-names>
</name>
<xref ref-type="aff" rid="a40">40</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0559-5301</contrib-id>
<name>
<surname>Ferre</surname>
<given-names>Laura</given-names>
</name>
<xref ref-type="aff" rid="a40">40</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-6862-9468</contrib-id>
<name>
<surname>Comi</surname>
<given-names>Cristoforo</given-names>
</name>
<xref ref-type="aff" rid="a43">43</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Galimberti</surname>
<given-names>Daniela</given-names>
</name>
<xref ref-type="aff" rid="a44">44</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Leone</surname>
<given-names>Maurizio</given-names>
</name>
<xref ref-type="aff" rid="a45">45</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-4376-2550</contrib-id>
<name>
<surname>Sorosina</surname>
<given-names>Melissa</given-names>
</name>
<xref ref-type="aff" rid="a40">40</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-9595-2914</contrib-id>
<name>
<surname>Mescheriakova</surname>
<given-names>Julia Y</given-names>
</name>
<xref ref-type="aff" rid="a46">46</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-2585-3643</contrib-id>
<name>
<surname>Hintzen</surname>
<given-names>Rogier</given-names>
</name>
<xref ref-type="aff" rid="a46">46</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-2374-9204</contrib-id>
<name>
<surname>Van Duijn</surname>
<given-names>Cornelia</given-names>
</name>
<xref ref-type="aff" rid="a46">46</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bos</surname>
<given-names>Steffan</given-names>
</name>
<xref ref-type="aff" rid="a47">47</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Myhr</surname>
<given-names>Kjell-Morten</given-names>
</name>
<xref ref-type="aff" rid="a48">48</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-9127-6488</contrib-id>
<name>
<surname>Celius</surname>
<given-names>Elisabeth Gulowsen</given-names>
</name>
<xref ref-type="aff" rid="a49">49</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lie</surname>
<given-names>Benedicte</given-names>
</name>
<xref ref-type="aff" rid="a50">50</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-4421-0766</contrib-id>
<name>
<surname>Spurkland</surname>
<given-names>Anne</given-names>
</name>
<xref ref-type="aff" rid="a51">51</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Comabella</surname>
<given-names>Manuel</given-names>
</name>
<xref ref-type="aff" rid="a52">52</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Montalban</surname>
<given-names>Xavier</given-names>
</name>
<xref ref-type="aff" rid="a52">52</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-1688-6697</contrib-id>
<name>
<surname>Alfredsson</surname>
<given-names>Lars</given-names>
</name>
<xref ref-type="aff" rid="a53">53</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-4855-0039</contrib-id>
<name>
<surname>Stridh</surname>
<given-names>Pernilla</given-names>
</name>
<xref ref-type="aff" rid="a54">54</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-7386-6732</contrib-id>
<name>
<surname>Hillert</surname>
<given-names>Jan</given-names>
</name>
<xref ref-type="aff" rid="a54">54</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0756-889X</contrib-id>
<name>
<surname>Jagodic</surname>
<given-names>Maja</given-names>
</name>
<xref ref-type="aff" rid="a54">54</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-8329-5219</contrib-id>
<name>
<surname>Piehl</surname>
<given-names>Fredrik</given-names>
</name>
<xref ref-type="aff" rid="a54">54</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-3090-7319</contrib-id>
<name>
<surname>Jelcic</surname>
<given-names>Ilijas</given-names>
</name>
<xref ref-type="aff" rid="a55">55</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Martin</surname>
<given-names>Roland</given-names>
</name>
<xref ref-type="aff" rid="a55">55</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-8333-7423</contrib-id>
<name>
<surname>Sospedra</surname>
<given-names>Mireia</given-names>
</name>
<xref ref-type="aff" rid="a55">55</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ban</surname>
<given-names>Maria</given-names>
</name>
<xref ref-type="aff" rid="a56">56</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hawkins</surname>
<given-names>Clive</given-names>
</name>
<xref ref-type="aff" rid="a57">57</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-5752-2510</contrib-id>
<name>
<surname>Hysi</surname>
<given-names>Pirro</given-names>
</name>
<xref ref-type="aff" rid="a58">58</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kalra</surname>
<given-names>Seema</given-names>
</name>
<xref ref-type="aff" rid="a59">59</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-2751-1770</contrib-id>
<name>
<surname>Karpe</surname>
<given-names>Fredrik</given-names>
</name>
<xref ref-type="aff" rid="a60">60</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0330-7844</contrib-id>
<name>
<surname>Khadake</surname>
<given-names>Jyoti</given-names>
</name>
<xref ref-type="aff" rid="a61">61</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-2507-5802</contrib-id>
<name>
<surname>Lachance</surname>
<given-names>Genevieve</given-names>
</name>
<xref ref-type="aff" rid="a58">58</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Neville</surname>
<given-names>Matthew</given-names>
</name>
<xref ref-type="aff" rid="a60">60</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Santaniello</surname>
<given-names>Adam</given-names>
</name>
<xref ref-type="aff" rid="a62">62</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Caillier</surname>
<given-names>Stacy</given-names>
</name>
<xref ref-type="aff" rid="a62">62</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-7776-6472</contrib-id>
<name>
<surname>Calabresi</surname>
<given-names>Peter</given-names>
</name>
<xref ref-type="aff" rid="a63">63</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-7689-2533</contrib-id>
<name>
<surname>Cree</surname>
<given-names>Bruce</given-names>
</name>
<xref ref-type="aff" rid="a62">62</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cross</surname>
<given-names>Anne</given-names>
</name>
<xref ref-type="aff" rid="a64">64</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Davis</surname>
<given-names>Mary</given-names>
</name>
<xref ref-type="aff" rid="a65">65</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Haines</surname>
<given-names>Jonathan</given-names>
</name>
<xref ref-type="aff" rid="a65">65</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-7735-7858</contrib-id>
<name>
<surname>de Bakker</surname>
<given-names>Paul</given-names>
</name>
<xref ref-type="aff" rid="a66">66</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Delgado</surname>
<given-names>Silvia</given-names>
</name>
<xref ref-type="aff" rid="a67">67</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-4865-7998</contrib-id>
<name>
<surname>Dembele</surname>
<given-names>Marieme</given-names>
</name>
<xref ref-type="aff" rid="a63">63</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Edwards</surname>
<given-names>Keith</given-names>
</name>
<xref ref-type="aff" rid="a68">68</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-2814-7461</contrib-id>
<name>
<surname>Hakonarson</surname>
<given-names>Hakon</given-names>
</name>
<xref ref-type="aff" rid="a69">69</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Konidari</surname>
<given-names>Ioanna</given-names>
</name>
<xref ref-type="aff" rid="a4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lathi</surname>
<given-names>Ellen</given-names>
</name>
<xref ref-type="aff" rid="a70">70</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Manrique</surname>
<given-names>Clara</given-names>
</name>
<xref ref-type="aff" rid="a4">4</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-7283-8804</contrib-id>
<name>
<surname>Pericak-Vance</surname>
<given-names>Margaret</given-names>
</name>
<xref ref-type="aff" rid="a4">4</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8760-109X</contrib-id>
<name>
<surname>Piccio</surname>
<given-names>Laura</given-names>
</name>
<xref ref-type="aff" rid="a71">71</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Schaefer</surname>
<given-names>Cathy</given-names>
</name>
<xref ref-type="aff" rid="a72">72</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>McCabe</surname>
<given-names>Cristin</given-names>
</name>
<xref ref-type="aff" rid="a73">73</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Weiner</surname>
<given-names>Howard</given-names>
</name>
<xref ref-type="aff" rid="a74">74</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Olsson</surname>
<given-names>Thomas</given-names>
</name>
<xref ref-type="aff" rid="a54">54</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-4002-2776</contrib-id>
<name>
<surname>Hadjigeorgiou</surname>
<given-names>Georgios</given-names>
</name>
<xref ref-type="aff" rid="a37">37</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Taylor</surname>
<given-names>Bruce</given-names>
</name>
<xref ref-type="aff" rid="a75">75</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tajoori</surname>
<given-names>Lotti</given-names>
</name>
<xref ref-type="aff" rid="a76">76</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-6201-3518</contrib-id>
<name>
<surname>Charlesworth</surname>
<given-names>Jac</given-names>
</name>
<xref ref-type="aff" rid="a77">77</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Booth</surname>
<given-names>David</given-names>
</name>
<xref ref-type="aff" rid="a78">78</xref>
</contrib>
<contrib contrib-type="author">
<collab>The Australia and New Zealand Genetics Consortium</collab>
</contrib>
<contrib contrib-type="author">
<collab>The Wellcome Trust Case Control Consortium 2</collab>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-6047-0122</contrib-id>
<name>
<surname>Harbo</surname>
<given-names>Hanne Flinstad</given-names>
</name>
<xref ref-type="aff" rid="a79">79</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ivinson</surname>
<given-names>Adrian</given-names>
</name>
<xref ref-type="aff" rid="a80">80</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hauser</surname>
<given-names>Stephen</given-names>
</name>
<xref ref-type="aff" rid="a81">81</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0734-0185</contrib-id>
<name>
<surname>Compston</surname>
<given-names>Alastair</given-names>
</name>
<xref ref-type="aff" rid="a81">81</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Stewart</surname>
<given-names>Graeme</given-names>
</name>
<xref ref-type="aff" rid="a78">78</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1231-1928</contrib-id>
<name>
<surname>Zipp</surname>
<given-names>Frauke</given-names>
</name>
<xref ref-type="aff" rid="a20">20</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Barcellos</surname>
<given-names>Lisa</given-names>
</name>
<xref ref-type="aff" rid="a82">82</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0067-194X</contrib-id>
<name>
<surname>Baranzini</surname>
<given-names>Sergio</given-names>
</name>
<xref ref-type="aff" rid="a81">81</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-8326-2249</contrib-id>
<name>
<surname>Martinelli Boneschi</surname>
<given-names>Filippo</given-names>
</name>
<xref ref-type="aff" rid="a83">83</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-3983-9925</contrib-id>
<name>
<surname>D'Alfonso</surname>
<given-names>Sandra</given-names>
</name>
<xref ref-type="aff" rid="a43">43</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8386-5397</contrib-id>
<name>
<surname>Ziegler</surname>
<given-names>Andreas</given-names>
</name>
<xref ref-type="aff" rid="a84">84</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Oturai</surname>
<given-names>Annette</given-names>
</name>
<xref ref-type="aff" rid="a85">85</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1805-1733</contrib-id>
<name>
<surname>McCauley</surname>
<given-names>Jacob</given-names>
</name>
<xref ref-type="aff" rid="a4">4</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-7685-0974</contrib-id>
<name>
<surname>Sawcer</surname>
<given-names>Stephen</given-names>
</name>
<xref ref-type="aff" rid="a56">56</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Oksenberg</surname>
<given-names>Jorge</given-names>
</name>
<xref ref-type="aff" rid="a81">81</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>De Jager</surname>
<given-names>Philip</given-names>
</name>
<xref ref-type="aff" rid="a86">86</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0867-4726</contrib-id>
<name>
<surname>Kockum</surname>
<given-names>Ingrid</given-names>
</name>
<xref ref-type="aff" rid="a54">54</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hafler</surname>
<given-names>David</given-names>
</name>
<xref ref-type="aff" rid="a87">87</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-7772-5910</contrib-id>
<name>
<surname>Cotsapas</surname>
<given-names>Chris</given-names>
</name>
<xref ref-type="aff" rid="a2">2</xref>
<xref ref-type="corresp" rid="cor1">88</xref>
</contrib>
<aff id="a2">
<label>2</label><institution>Yale School of Medicine;</institution>
</aff>
<aff id="a3">
<label>3</label><institution>Brigham &#x0026; Women&#x2019;s Hospital</institution>, Boston, MA;
</aff>
<aff id="a4">
<label>4</label><institution>University of Miami, Miller School of Medicine</institution>, Miami, FL;
</aff>
<aff id="a5">
<label>5</label><institution>Institute of Medical Biometry and Statistics, University of Lubeck</institution>, Germany;
</aff>
<aff id="a6">
<label>6</label><institution>Department of Neurosciences, Laboratory for Neuroimmunology</institution>, Leuven, Belgium;
</aff>
<aff id="a7">
<label>7</label><institution>National Multiple Sclerosis Center</institution>, Melsbroek, Belgium;
</aff>
<aff id="a8">
<label>8</label><institution>Department of Neurology, Johns Hopkins University School of Medicine</institution>, Baltimore MD;
</aff>
<aff id="a9">
<label>9</label><institution>Danish Multiple Sclerosis Center, Department of Neurology, Rigshospitalet, University of Copenhagen;</institution>
</aff>
<aff id="a10">
<label>10</label><institution>Department of Clinical Immunology, Rigshospitalet, University of Copenhagen</institution>, Denmark;
</aff>
<aff id="a11">
<label>11</label><institution>Department of Clinical Immunology, Center of Clinical Investigation, Copenhagen University Hospital;</institution>
</aff>
<aff id="a12">
<label>12</label><institution>Institute of Biological Psychiatry, Mental Health Center Sct. Hans, Univ of Copenhagen</institution>, <country>Denmark</country>
</aff>
<aff id="a13">
<label>13</label><institution>Institute for Molecular Medicine Finland, University of Helsinki</institution>, Helsinki, <country>Finland</country>
</aff>
<aff id="a14">
<label>14</label><institution>Departement de Neurologie Pitie-Salpetriere</institution>, PARIS, <country>France</country>
</aff>
<aff id="a15">
<label>15</label><institution>Commissariat a l&#x2019;Energie Atomique, Institut Genomique, Centre National de Genotypage</institution>, Evry, <country>France</country>
</aff>
<aff id="a16">
<label>16</label><institution>Observatoire Francais de la Sclerose en Plaques (OFSEP) Hopital Neurologique cedex</institution> - <country>France</country>
</aff>
<aff id="a17">
<label>17</label><institution>Universite de Nantes, INSERM, Centre de Recherche en Transplantation et Immunologie</institution>, Nantes, <country>France</country>
</aff>
<aff id="a18">
<label>18</label><institution>Max Planck Institute of Psychiatry</institution>, 80804 Munich, <country>Germany</country>
</aff>
<aff id="a19">
<label>19</label><institution>Department of Neurology, Klinikum rechts der Isar, Technische Universitat Munchen</institution>, <country>Germany</country>
</aff>
<aff id="a20">
<label>20</label><institution>Johannes Gutenberg University-Medical Center</institution>, Mainz, <country>Germany</country>
</aff>
<aff id="a21">
<label>21</label><institution>Department of Neurology Klinikum Augsburg</institution>, Stenglingstr. 2, 86156 Augsburg;
</aff>
<aff id="a22">
<label>22</label><institution>Department of Neurology, Universitatsklinikum Hamburg Eppendorf</institution>, Martinistr. 52, 20246 Hamburg;
</aff>
<aff id="a23">
<label>23</label><institution>Department of Neuroimmunology, Klinikum GroBhadern</institution>, Marchioninistr.15, 81377 Munchen;
</aff>
<aff id="a24">
<label>24</label><institution>Department of Neurology Universitatsklinikum Erlangen</institution>, Maximiliansplatz 2, 91054 Erlangen;
</aff>
<aff id="a25">
<label>25</label><institution>NeruoCure Clinical Research Center</institution>, Charite Campus Mitte Chariteplatz 1, 10117 Berlin;
</aff>
<aff id="a26">
<label>26</label><institution>Department of Neurology, Medizinische Hochschule Hannover</institution>, Carl-Neuberg-Str. 1, 30625 Hannover;
</aff>
<aff id="a27">
<label>27</label><institution>Department of Neurology, Universitatsklinikum GieBen/Marburg</institution>, Baldingerstr., 35043 Marburg;
</aff>
<aff id="a28">
<label>28</label><institution>Department of Neurology, Universitatsklinikum Leipzig</institution>, Liebigstr. 20, 04103 Leipzig;
</aff>
<aff id="a29">
<label>29</label><institution>Department of Neurology, Universitatsklinikum Koln</institution>, Kerpener Str. 62, 50937 Koln;
</aff>
<aff id="a30">
<label>30</label><institution>Department of Neurology, Universitatsklinikum Munster</institution>, Albert-Schweitzer-Campus 1, 48149 Munster;
</aff>
<aff id="a31">
<label>31</label><institution>Department of Neurology, Universitatsklinikum Heidelberg</institution>, Im Neuenheimer Feld 400, 69120 Heidelberg;
</aff>
<aff id="a32">
<label>32</label><institution>Department of Neurology, Universitatsklinikum Rostock</institution>, Schillingallee 35, 18057 Rostock;
</aff>
<aff id="a33">
<label>33</label><institution>Department of Neurology, Universitatsklinikum Tubingen</institution>, Tubingen;
</aff>
<aff id="a34">
<label>34</label><institution>Fachklinik fur Neurologie, Akademisches Krankenhaus der Universitat Ulm</institution>, Dietenbronn 7, 88477 Schwen;
</aff>
<aff id="a35">
<label>35</label><institution>Department of Neurology, Ruhr Universitat Bochum, St. Josef Hospital</institution>, Gudrunstr. 56, 44791 Bochum;
</aff>
<aff id="a36">
<label>36</label><institution>Department of Neurology, University Medical Center of the Johannes Gutenberg Mainz</institution>, <country>Germany</country>
</aff>
<aff id="a37">
<label>37</label><institution>Neurology Dpt, Neurogenetics Lab, University Hospital of Larissa</institution>, <country>Greece</country>
</aff>
<aff id="a38">
<label>38</label><institution>Laboratory of Molecular Medicine and Biotechnology, Don C. Gnocchi Foundation ONLUS</institution>, Milan, <country>Italy</country>
</aff>
<aff id="a39">
<label>39</label><institution>Department of Health Sciences and IRCAD, University of Eastern Piedmont</institution>, Novara, <country>Italy</country>
</aff>
<aff id="a40">
<label>40</label><institution>Division of Neuroscience, San Raffaele Scientific Institute</institution>, Via Olgettina 58, 20132, Milan, <country>Italy</country>
</aff>
<aff id="a41">
<label>41</label><institution>Medical Research Council Biostatistics Unit</institution>, Robinson Way, Cambridge CB2 0SR, <country>UK</country>
</aff>
<aff id="a42">
<label>42</label><institution>University of Milan, Department of Health Sciences</institution>, Milan, <country>Italy</country>
</aff>
<aff id="a43">
<label>43</label><institution>University of Eastern Piedmont</institution>, Novara, <country>Italy</country>
</aff>
<aff id="a44">
<label>44</label><institution>Neurology Unit, Dept. of Pathophysiology and Transplantation, University of Milan</institution>
</aff>
<aff id="a45">
<label>45</label><institution>Department of Neurology, Ospedale Maggiore</institution>, Novara, <country>Italy</country>
</aff>
<aff id="a46">
<label>46</label><institution>Department of Neurology, Erasmus MC</institution>, Rotterdam, <country>Netherlands</country>
</aff>
<aff id="a47">
<label>47</label><institution>Department of Neurology, Institute of Clinical Medicine, University of Oslo</institution>, <country>Norway</country>
</aff>
<aff id="a48">
<label>48</label><institution>Department of Neurology, Haukeland University Hospital</institution>, Bergen, <country>Norway</country>
</aff>
<aff id="a49">
<label>49</label><institution>Department of Neurology, Oslo University Hospital</institution>, Oslo <country>Norway</country>
</aff>
<aff id="a50">
<label>50</label><institution>Department of medical genetics, Oslo University Hospitael</institution>
</aff>
<aff id="a51">
<label>51</label><institution>Institute of Basic Medical Sciences, University of Oslo</institution>, <country>Norway</country>
</aff>
<aff id="a52">
<label>52</label><institution>Institut de Recerca Vall dHebron (VHIR). Hospital Universitari Vall dHebron</institution>, Barcelona, <country>Spain</country>
</aff>
<aff id="a53">
<label>53</label><institution>Institute of Environmental Medicine, Karolinska Institutet</institution>, Stockholm, <country>Sweden</country>
</aff>
<aff id="a54">
<label>54</label><institution>Department of Clinical Neuroscience, Karolinska Institutet</institution>, Stockholm, <country>Sweden</country>
</aff>
<aff id="a55">
<label>55</label><institution>Neuroimmunology and MS Research (nims), Neurology Clinic, University Hospital Zurich</institution>, <country>Switzerland</country>
</aff>
<aff id="a56">
<label>56</label><institution>University of Cambridge, Department of Clinical Neurosciences, Addenbrooke&#x2019;s Hospital</institution>, Cambridge, <country>UK</country>
</aff>
<aff id="a57">
<label>57</label><institution>Keele University Medical School, University Hospital of North Staffordshire</institution>, NY, UK;
</aff>
<aff id="a58">
<label>58</label><institution>Department of Twin Research and Genetic Epidemiology, Kings College London</institution>, London, UK;
</aff>
<aff id="a59">
<label>59</label><institution>Keele University Medical School, University Hospital of North Midlands</institution>, Stoke-on-Trent ST4 7NY, UK;
</aff>
<aff id="a60">
<label>60</label><institution>Radcliffe Department of Medicine, University of Oxford</institution>, Oxford, UK;
</aff>
<aff id="a61">
<label>61</label><institution>NIHR BioResource, University of Cambridge and Cambridge University Hospitals</institution>, Cambridge, UK;
</aff>
<aff id="a62">
<label>62</label><institution>Department of Neurology, University of California</institution>, San Francisco, CA;
</aff>
<aff id="a63">
<label>63</label><institution>Department of Neurology, Johns Hopkins University School of medicine</institution>, Baltimore MD;
</aff>
<aff id="a64">
<label>64</label><institution>Multiple Sclerosis Center, Dept of Neurology, School of Medicine, Washington University St Louis</institution>, MO;
</aff>
<aff id="a65">
<label>65</label><institution>Center for Human Genetics Research, Vanderbilt University Medical Center</institution>, Nashville, TN;
</aff>
<aff id="a66">
<label>66</label><institution>Vertex Pharmaceuticals</institution>, Boston MA;
</aff>
<aff id="a67">
<label>67</label><institution>Department of Neurology, University of Miami, Miller School of Medicine</institution>, Miami, FL;
</aff>
<aff id="a68">
<label>68</label><institution>MS center of northeastern</institution> NY 1205 Troy Schenectady Rd, Latham, NY;
</aff>
<aff id="a69">
<label>69</label><institution>Center for Applied Genomics, The Children&#x2019;s Hospital of Philadelphia</institution>, PA;
</aff>
<aff id="a70">
<label>70</label><institution>The Elliot Lewis Center</institution>, 110 Cedar St, Wellesley MA,;
</aff>
<aff id="a71">
<label>71</label><institution>Department of neurology, School of medicine, Washington University St Louis</institution>, St Louis MO;
</aff>
<aff id="a72">
<label>72</label><institution>Kaiser Permanente Divison of Research</institution>, Oakland, CA;
</aff>
<aff id="a73">
<label>73</label><institution>Broad Institute of Harvard University and MIT</institution>, Cambridge, MA;
</aff>
<aff id="a74">
<label>74</label><institution>Department of Neurology, Brigham &#x0026; Women&#x2019;s Hospital</institution>, Boston. MA;
</aff>
<aff id="a75">
<label>75</label><institution>Menzies Research Institute Tasmania, University of Tasmania</institution>
</aff>
<aff id="a76">
<label>76</label><institution>Health Sciences and Medicine Bond University, Gold Coast Queensland</institution>, <country>Australia</country>
</aff>
<aff id="a77">
<label>77</label><institution>Menzies Institute for Medical Research, University of Tasmania</institution>
</aff>
<aff id="a78">
<label>78</label><institution>Westmead Millennium Institute, University of Sydney</institution>, New South Wales, Australia;
</aff>
<aff id="a79">
<label>79</label><institution>Department of Neurology, Oslo University Hospital</institution>, Oslo, Norway;
</aff>
<aff id="a80">
<label>80</label><institution>Department of Neurology, Brigham &#x0026; Women&#x2019;s Hospital</institution>, Boston, MA;
</aff>
<aff id="a81">
<label>81</label><institution>Department of Neurology, University of California at San Francisco</institution>, CA;
</aff>
<aff id="a82">
<label>82</label><institution>UC Berkeley School of Public Health and Center for Computational Biology</institution>
</aff>
<aff id="a83">
<label>83</label><institution>Division of Neuroscience, San Raffaele Scientific Institute</institution>, Milan, <country>Italy</country>
</aff>
<aff id="a84">
<label>84</label><institution>University of Lubeck, University Medical Center Schleswig-Holstein</institution>, Lubeck;
</aff>
<aff id="a85">
<label>85</label><institution>Danish Multiple Sclerosis Center, Department of Neurology, University of Copenhagen</institution>, Denmark;
</aff>
<aff id="a86">
<label>86</label><institution>Department of Neurology, Columbia University Medical Center</institution>, New York, NY;
</aff>
<aff id="a87">
<label>87</label><institution>Departments of Neurology and Immunobiology, Yale University School of Medicine</institution>, New Haven, CT
</aff>
</contrib-group>
<author-notes>
<corresp id="cor1"><label>&#x002A;</label> Corresponding author; email: <email>cotsapas@broadinstitute.org</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<year>2018</year>
</pub-date>
<elocation-id>286617</elocation-id>
<history>
<date date-type="received">
<day>23</day>
<month>3</month>
<year>2018</year>
</date>
<date date-type="rev-recd">
<day>23</day>
<month>3</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>23</day>
<month>3</month>
<year>2018</year>
</date>
</history>
<permissions>
<copyright-statement>&#x00A9; 2018, Posted by Cold Spring Harbor Laboratory</copyright-statement>
<copyright-year>2018</copyright-year>
<license license-type="creative-commons" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This pre-print is available under a Creative Commons License (Attribution 4.0 International), CC BY 4.0, as described at <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link></license-p></license>
</permissions>
<self-uri xlink:href="286617.pdf" content-type="pdf" xlink:role="full-text"/>
<abstract>
<title>Abstract</title>
<p>Multiple sclerosis is a common, complex neurological disease, where almost 20&#x0025; of risk heritability can be attributed to common genetic variants, including &#x003E;230 identified by genome-wide association studies (<xref ref-type="bibr" rid="c28">Patsopoulos et al., 2017</xref>). Multiple strands of evidence suggest that the majority of the remaining heritability is also due to the additive effects of individual variants, rather than epistatic interactions between these variants, or mutations exclusive to individual families. Here, we show in 68,379 cases and controls that as much as 5&#x0025; of this heritability is explained by low-frequency variation in gene coding sequence. We identify four novel genes driving MS risk independently of common variant signals, which highlight a key role for regulatory T cell homeostasis and regulation, IFN&#x03B3; biology and NF&#x03BA;B signaling in MS pathogenesis. As low-frequency variants do not show substantial linkage disequilibrium with other variants, and as coding variants are more interpretable and experimentally tractable than non-coding variation, our discoveries constitute a rich resource for dissecting the pathobiology of MS.</p>
</abstract>
<counts>
<page-count count="22"/>
</counts>
</article-meta>
</front>
<body>
<sec id="s1">
<title>Main text</title>
<p>Multiple sclerosis (MS; MIM 126200) is an autoimmune disease of the central nervous system and a common cause of neurologic disability in young adults (<xref ref-type="bibr" rid="c8">Compston and Coles, 2008</xref>). It is most prevalent in individuals of northern European ancestry and &#x2013; in line with other complex, common disorders &#x2013; shows substantial heritability (<xref ref-type="bibr" rid="c6">Binder et al., 2016</xref>), with a sibling standardized incidence ratio of 7.1 (<xref ref-type="bibr" rid="c38">Westerlind et al., 2014</xref>). Over the last fifteen years, we have identified 233 independent, common variant associations mediating disease risk by genome-wide association studies (GWAS) of increasing sample size (<xref ref-type="bibr" rid="c2">Andlauer et al., 2016</xref>; <xref ref-type="bibr" rid="c3">Australia and New Zealand Multiple Sclerosis Genetics Consortium, 2009</xref>; <xref ref-type="bibr" rid="c4">Baranzini et al., 2009</xref>; <xref ref-type="bibr" rid="c11">de Jager et al., 2009</xref>; <xref ref-type="bibr" rid="c16">International Multiple Sclerosis Genetics Consortium, 2013</xref>; 2011; <xref ref-type="bibr" rid="c18">Jakkula et al., 2010</xref>; <xref ref-type="bibr" rid="c23">Martinelli-Boneschi et al., 2012</xref>; <xref ref-type="bibr" rid="c26">Nischwitz et al., 2010</xref>; Patsopoulos et al., 2011; 2017; <xref ref-type="bibr" rid="c31">Sanna et al., 2010</xref>; <xref ref-type="bibr" rid="c37">Wellcome Trust Case Control Consortium, 2007</xref>). Cumulatively, these effects &#x2013; including 32 mapping to classical human leukocyte antigen (HLA) alleles and other variation in the major histocompatibility (MHC) locus (<xref ref-type="bibr" rid="c24">Moutsianas et al., 2015</xref>; Patsopoulos et al., 2013; 2017) &#x2013; account for 7.5&#x0025; of <italic>h</italic><sup><italic>2</italic></sup><italic>g</italic>, the heritability attributable to additive genetic effects captured by genotyping arrays, with a total of 19.2&#x0025; of <italic>h2g</italic> attributable to all common variants in the autosomal genome (<xref ref-type="bibr" rid="c28">Patsopoulos et al., 2017</xref>). MS is thus a prototypical complex disease with a substantial portion of heritability determined by hundreds of common genetic variants, each of which explain only a small fraction of risk (<xref ref-type="bibr" rid="c33">Sawcer et al., 2014</xref>).</p>
<p>As with other common, complex diseases where large GWAS have been conducted, we find that although common variants (minor allele frequency, MAF &#x003E; 5&#x0025;) account for the bulk of trait heritability, they cannot account for its entirety. Identifying the source of this unexplained heritability has thus become a major challenge (<xref ref-type="bibr" rid="c21">Manolio et al., 2009</xref>). Two hypotheses are frequently advanced: that some common variants show epistatic (i.e. non-additive) interactions, so that they contribute more risk in combination than each does alone; and that a portion of risk is due to rare variants that cannot be imputed via linkage disequilibrium to common variants present on genotyping arrays, and are therefore invisible to heritability calculations based on such arrays. The only evidence we have found for epistatic interactions between common MS risk variants is being between two HLA haplotype families in the MHC locus (<xref ref-type="bibr" rid="c24">Moutsianas et al., 2015</xref>). This lack of epistatic interactions is consistent with other common, complex diseases, both of the immune system and beyond (<xref ref-type="bibr" rid="c1">Altshuler et al., 2008</xref>). We have also found no evidence that mutations in individual families drive disease risk in genome-wide linkage analyses of 730 MS families with multiple affected members (<xref ref-type="bibr" rid="c32">Sawcer et al., 2005</xref>). These results indicate that neither epistasis between known risk variants nor mutations in a limited number of loci are major sources of MS risk. They do not, however, preclude a role for variants present in the population at low frequencies, which cannot be imputed but are likely to individually contribute moderate risk.</p>
<p>Here, we report our assessment of the contribution of low-frequency variation in gene coding regions to MS risk. We conducted a meta-analysis of 144,209 low-frequency coding variants across all autosomal exons, concentrating on non-synonymous variants, which are more likely to have a phenotypic effect. We analyzed a total of 32,367 MS cases and 36,012 controls drawn from centers across Australia, ten European countries and multiple US states, which we genotyped either on the Illumina HumanExome Beadchip (exome chip) or on a custom array (the MS Chip) incorporating the exome chip content (<xref ref-type="bibr" rid="c28">Patsopoulos et al., 2017</xref>), and which satisfied our stringent quality control filters (<xref rid="figS1" ref-type="fig">Figure S1</xref> and Tables S1 and S2). The exome array is a cost-efficient alternative to exome sequencing, capturing approximately 88&#x0025; of low frequency and rare coding variants present in 33,370 non-Finnish Europeans included in the Exome Aggregation Consortium (minor allele frequencies between 0.0001 and 0.05; <xref rid="figS2" ref-type="fig">Figure S2</xref>), and &#x003C;5&#x0025; of the extremely rare alleles present at even lower frequencies. Our study was well powered, with 80&#x0025; power to detect modest effects at low-frequency (odds ratio OR = 1.15 at MAF = 5&#x0025;) and rare variants (OR = 1.5 at MAF = 0.5&#x0025;) at a significance threshold of <italic>p &#x003C; 3.5 &#x00D7;10</italic><sup><italic>-7</italic></sup> (Bonferroni correction for the total number of variants genotyped).</p>
<p>We first assessed the contribution of individual variants to MS risk by conducting a meta-analysis of association statistics across 14 country-level strata (<xref rid="fig1" ref-type="fig">Figure 1</xref>). We used linear mixed models to correct for population structure in 13 of these strata, estimated from the 16,066 common, synonymous coding variants present on the exome chip (i.e. variants with minor allele frequency MAF &#x003E; 5&#x0025; in our samples). We included population structure-corrected summary statistics for the remaining cohort (from Germany), which has been previously described (<xref ref-type="bibr" rid="c10">Dankowski et al., 2015</xref>). As expected, we saw a strong correlation between effect size and variant frequency, with rarer alleles exerting larger effects (<xref rid="figS3" ref-type="fig">Figure S3</xref>). We found significant association between MS risk and seven low-frequency coding variants in six genes outside the extended MHC locus on chromosome 6 (<xref rid="tbl1" ref-type="table">Table 1</xref> and <xref rid="figS4" ref-type="fig">Figure S4</xref>). Two of these variants (<italic>TYK2</italic> c.3310C&#x003E;G, p.Pro1104Ala, overall MAF 4.1&#x0025; in our samples; and <italic>GALC</italic> p.Asp84Asp, overall MAF 3.9&#x0025;), are in regions identified by our latest MS GWAS, and show linkage disequilibrium with the common variant associations we have previously reported (International Multiple Sclerosis Genetics Consortium, 2011). The remaining variants are novel and are in neither linkage disequilibrium or physical proximity to common variant association signals.</p>
<table-wrap id="tbl1" orientation="portrait" position="float">
<label>Table 1</label>
<caption><title>coding variants associated to multiple sclerosis risk</title>
<p>We analyzed 144,209 low-frequency non-synonymous coding variants across all autosomal exons in 32,367 MS cases and 36,012 controls drawn from centers across Australia, ten European countries and multiple US states. Genome positions are relative to hg19. The two variants in <italic>PRKRA</italic> are in linkage disequilibrium (R<sup>2</sup> = 1, D = 1 in HapMap 3 European samples). &#x002A; These variants lie in common variant risk loci found in our previous GWAS (<xref ref-type="bibr" rid="c28">Patsopoulos et al., 2017</xref>).</p></caption>
<graphic xlink:href="286617v1_tbl1.tif"/>
</table-wrap>
<fig id="fig1" position="float" fig-type="figure">
<label>Figure 1</label>
<caption><title>rare coding variants are associated to multiple sclerosis risk in a multi-cohort study</title>
<p>We analyzed 144,209 low-frequency non-synonymous coding variants across all autosomal exons in 32,367 MS cases and 36,012 controls drawn across the International Multiple Sclerosis Genetics Consortium centers. We find evidence for association with both common variants with combined MAF &#x003E;5&#x0025; (A); and with rare variants across the autosomes (B). We sourced samples from Australia, ten European countries, and the USA (C).</p></caption>
<graphic xlink:href="286617v1_fig1.tif"/>
</fig>
<p>The newly discovered genes have clear immunological functions, confirming that MS pathogenesis is primarily driven by immune dysfunction. The associated polymorphisms show negligible linkage disequilibrium with other variants, so the genes harboring them are likely to be relevant to disease. <italic>PRF1</italic> encodes perforin, a key component of the granzyme-mediated cytotoxicity pathways used by several lymphocyte populations. In addition to cytotoxic lymphocytes and natural killer cells (<xref ref-type="bibr" rid="c14">House et al., 2015</xref>), perforin-dependent cytotoxicity is also seen in CD4<sup>&#x002B;</sup>FOXP3<sup>&#x002B;</sup> regulatory T cells (Tregs), which show aberrant, T-helper-like IFN&#x03B3; secretion in MS patients (<xref ref-type="bibr" rid="c12">Dominguez-Villar et al., 2011</xref>). The MS risk variant rs35947132 (p.Ala91Val) is associated with a decrease in target cell killing efficiency and increases in IFN&#x03B3; secretion by NK cells (<xref ref-type="bibr" rid="c14">House et al., 2015</xref>), which aligns with the aberrant Treg phenotype observed in MS. This decreased cytotoxicity efficiency will prolong average cell-cell interactions with target cells, and such extended interactions are known to increase T cell receptor-mediated signaling and induce changes to T cell phenotypes, especially secretion of IFN&#x03B3; and other cytokines (<xref ref-type="bibr" rid="c9">Constant et al., 1995</xref>). Similarly, <italic>HDAC7</italic> encodes the class II histone deacetylase 7, which potentiates the repressive effects of <italic>FOXP3</italic>, the master regulator governing na&#x00EF;ve CD4<sup>&#x002B;</sup> T cell development into Tregs (<xref ref-type="bibr" rid="c5">Bettini et al., 2012</xref>; <xref ref-type="bibr" rid="c19">Li et al., 2007</xref>). <italic>PRKRA</italic> encodes protein kinase interferon-inducible double-stranded RNA-dependent activator; in response to double-stranded RNA due to virus infection, it heterodimerizes with protein kinase R to inhibit EIF2a-dependent translation, resulting in upregulation of NF&#x03BA;B signaling, interferon production and, eventually, apoptosis (<xref ref-type="bibr" rid="c30">Sadler and Williams, 2008</xref>). NF&#x03BA;B-mediated signaling is a core feature of MS pathogenesis, which we have shown to be altered by at least one MS-associated variant (<xref ref-type="bibr" rid="c15">Housley et al., 2015</xref>), and may be the relevant mechanism for this gene. Finally, <italic>NLRP8</italic> is an intracellular cytosolic receptor active in innate immune responses; the Ile942Met MS risk variant rs61734100 is detected only in individuals with European ancestry in ExAC.</p>
<p>Though we are able to identify individual low-frequency variants associated with MS risk, we recognize that we cannot detect all such variants at genome-wide significance. We thus sought to quantify the overall contribution of low-frequency coding variation to MS risk. In each of the thirteen strata that comprise our data, we estimated the proportion of heritability explained by common (MAF &#x003E; 5&#x0025;) and low-frequency (MAF &#x003C; 5&#x0025;) variants on the exome arrays (<xref ref-type="bibr" rid="c39">Yang et al., 2011</xref>). We included genotype-derived principal components to further control for population stratification. By meta-analyzing these estimates across the twelve strata where the restricted maximum likelihood model converged, we found that low-frequency variants explain 11.34&#x0025; (95&#x0025; confidence interval 11.33&#x0025;-11.35&#x0025;) of the observed difference between cases and controls (mean estimate 4.1&#x0025; on the liability scale; <xref rid="fig2" ref-type="fig">Figure 2</xref>). We further partitioned the low-frequency variants into intermediate (5&#x0025; &#x003E; MAF &#x003E; 1 &#x0025;) and rare (MAF &#x003C;1&#x0025;), and found that the latter alone explain 9.0&#x0025; (95&#x0025; confidence interval 8.9&#x0025;-9.1&#x0025;) on the observed scale (mean estimate 3.2&#x0025; on the liability scale; <xref rid="fig2" ref-type="fig">Figure 2</xref>). We note that six of the eight genome-wide significant variants presented in <xref rid="tbl1" ref-type="table">Table 1</xref> are of intermediate frequency, and thus are not included in the rare category. Our results thus indicate that many more rare non-synonymous variants contribute to MS risk but are not individually detectable at genome-wide thresholds even in large studies like ours.</p>
<fig id="fig2" position="float" fig-type="figure">
<label>Figure 2</label>
<caption><title>rare variants explain a substantial portion of multiple sclerosis heritability</title>
<p>We estimated the MS risk heritability explained by common variants (MAF &#x003E; 5&#x0025;) and low-frequency nonsynonymous coding variation (MAF &#x003C; 5&#x0025;) in each of thirteen cohorts genotyped on the exome chip, using GCTA (top panel). By meta-analyzing these estimates across cohorts, we found that low-frequency variants explain 11.34&#x0025; of heritability on the observed scale, which corresponds to 4.1&#x0025; on the liability scale (right top). After dividing the low-frequency variants into intermediate (5&#x0025; &#x003E; MAF &#x003E; 1 &#x0025;) and rare (MAF &#x003C;1&#x0025;; bottom panel), we found that the latter alone explain 9.0&#x0025; heritability on the observed scale (3.2&#x0025; on the liability scale; bottom right). Meta-analysis confidence intervals are small and visually occluded by the mean estimate plot characters. Cohorts (abbreviations as in <xref ref-type="table" rid="tblS1">Table S1</xref>) are ordered by sample size, with the percentage of the overall sample size shown in each subplot title. We could not obtain estimates for either model for our Finnish cohort (see Methods; not shown), or for the three-component model for our Belgian cohort (bottom panel, top row, fourth from left). Both cohorts are small, which may explain the failure to converge.</p></caption>
<graphic xlink:href="286617v1_fig2.tif"/>
</fig>
<p>In this study, we show that low frequency coding variation explains a fraction of MS risk, which cannot be attributed to common variants across the genome. We capture most, but not all, low-frequency missense variants (<xref rid="figS2" ref-type="fig">Figure S2</xref>), suggesting our heritability estimates for low-frequency and rare variation are conservative. This broadly agrees with previous reports that such variants contribute to complex traits, including Alzheimer disease (<xref ref-type="bibr" rid="c35">Sims et al., 2017</xref>) and schizophrenia (<xref ref-type="bibr" rid="c29">Purcell et al., 2015</xref>), where heritability modeling similar to ours supports a role for rare variants. Studies of quantitative phenotypes shared by the entire population, such as height (<xref ref-type="bibr" rid="c22">Marouli et al., 2017</xref>), serum lipid levels (<xref ref-type="bibr" rid="c20">Liu et al., 2017</xref>) and blood cell traits (<xref ref-type="bibr" rid="c7">Chami et al., 2016</xref>; <xref ref-type="bibr" rid="c36">The CHARGE Consortium Hematology Working Group, 2016</xref>), have also reported novel associations to low-frequency coding variants outside the large number of known GWAS loci in each trait. However, a meta-analysis of different type 2 diabetes study designs found no associations outside common variant GWAS regions (<xref ref-type="bibr" rid="c13">Fuchsberger et al., 2016</xref>), though this may be due to the heterogeneity of sample ascertainment and study design. In aggregate, therefore, our results and these past studies demonstrate that rare coding variants contribute a fraction of common, complex trait heritability. These results also agree with both theoretical expectation and empirical observations that low-frequency coding variants are under natural selection, and are unlikely to increase in frequency in the population (<xref ref-type="bibr" rid="c25">Nelson et al., 2012</xref>; <xref ref-type="bibr" rid="c34">Schoech et al., 2017</xref>; <xref ref-type="bibr" rid="c40">Zeng et al., 2017</xref>). Thus, some portion of disease-associated variants, and hence the genes they influence, may not be detectable with conventional GWAS designs. Our discovery of multiple risk-associated genes that are central to IFN&#x03B3; biology, Treg function and the NF&#x03BA;B signaling pathway in MS pathogenesis, and that do not reside in &#x003E;200 known MS risk loci, supports this view.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgements</title>
<p>A full list of acknowledgements appears in the supplementary material.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="c1"><mixed-citation publication-type="journal"><string-name><surname>Altshuler</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Daly</surname>, <given-names>M.J.</given-names></string-name>, and <string-name><surname>Lander</surname>, <given-names>E.S.</given-names></string-name> (<year>2008</year>). <article-title>Genetic Mapping in Human Disease</article-title>. <source>Science</source> <volume>322</volume>, <fpage>881</fpage>&#x2013;<lpage>888</lpage>.</mixed-citation></ref>
<ref id="c2"><mixed-citation publication-type="journal"><string-name><surname>Andlauer</surname>, <given-names>T.F.M.</given-names></string-name>, <string-name><surname>Buck</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Antony</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Bayas</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Bechmann</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Berthele</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Chan</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Gasperi</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Gold</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Graetz</surname>, <given-names>C.</given-names></string-name>, <etal>et al.</etal> (<year>2016</year>). <article-title>Novel multiple sclerosis susceptibility loci implicated in epigenetic regulation</article-title>. <source>Sci Adv</source> <volume>2</volume>, <fpage>e1501678</fpage>&#x2013;<lpage>e1501678</lpage>.</mixed-citation></ref>
<ref id="c3"><mixed-citation publication-type="journal"><collab>Australia and New Zealand Multiple Sclerosis Genetics Consortium</collab> (<year>2009</year>). <article-title>Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20</article-title>. <source>Nature Genetics</source> <volume>41</volume>, <fpage>824</fpage>&#x2013;<lpage>828</lpage>.</mixed-citation></ref>
<ref id="c4"><mixed-citation publication-type="journal"><string-name><surname>Baranzini</surname>, <given-names>S.E.</given-names></string-name>, <string-name><surname>Galwey</surname>, <given-names>N.W.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Khankhanian</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Lindberg</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Pelletier</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Wu</surname>, <given-names>W.</given-names></string-name>, <string-name><surname>Uitdehaag</surname>, <given-names>B.M.J.</given-names></string-name>, <string-name><surname>Kappos</surname>, <given-names>L.</given-names></string-name>, <string-name><given-names>GeneMSA</given-names> <surname>Consortium</surname></string-name>, <etal>et al.</etal> (<year>2009</year>). <article-title>Pathway and network-based analysis of genome-wide association studies in multiple sclerosis</article-title>. <source>Hum. Mol. Genet</source>. <volume>18</volume>, <fpage>2078</fpage>&#x2013;<lpage>2090</lpage>.</mixed-citation></ref>
<ref id="c5"><mixed-citation publication-type="journal"><string-name><surname>Bettini</surname>, <given-names>M.L.</given-names></string-name>, <string-name><surname>Pan</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Bettini</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Finkelstein</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Rehg</surname>, <given-names>J.E.</given-names></string-name>, <string-name><surname>Floess</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Bell</surname>, <given-names>B.D.</given-names></string-name>, <string-name><surname>Ziegler</surname>, <given-names>S.F.</given-names></string-name>, <string-name><surname>Huehn</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Pardoll</surname>, <given-names>D.M.</given-names></string-name>, <etal>et al.</etal> (<year>2012</year>). <article-title>Loss of Epigenetic Modification Driven by the Foxp3 Transcription Factor Leads to Regulatory T Cell Insufficiency</article-title>. <source>Immunity</source> <volume>36</volume>, <fpage>717</fpage>&#x2013;<lpage>730</lpage>.</mixed-citation></ref>
<ref id="c6"><mixed-citation publication-type="journal"><string-name><surname>Binder</surname>, <given-names>M.D.</given-names></string-name>, <string-name><surname>Fox</surname>, <given-names>A.D.</given-names></string-name>, <string-name><surname>Merlo</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Johnson</surname>, <given-names>L.J.</given-names></string-name>, <string-name><surname>Giuffrida</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Calvert</surname>, <given-names>S.E.</given-names></string-name>, <string-name><surname>Akkermann</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Ma</surname>, <given-names>G.Z.M.</given-names></string-name>, <collab>ANZgene</collab>, <string-name><surname>Perera</surname>, <given-names>A.A.</given-names></string-name>, <etal>et al.</etal> (<year>2016</year>). <article-title>Common and Low Frequency Variants in MERTK Are Independently Associated with Multiple Sclerosis Susceptibility with Discordant Association Dependent upon HLA-DRB1&#x002A;15 : 01 Status</article-title>. <source>PLoS Genetics</source> <volume>12</volume>, <fpage>e1005853</fpage>.</mixed-citation></ref>
<ref id="c7"><mixed-citation publication-type="journal"><string-name><surname>Chami</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Chen</surname>, <given-names>M.-H.</given-names></string-name>, <string-name><surname>Slater</surname>, <given-names>A.J.</given-names></string-name>, <string-name><surname>Eicher</surname>, <given-names>J.D.</given-names></string-name>, <string-name><surname>Evangelou</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Tajuddin</surname>, <given-names>S.M.</given-names></string-name>, <string-name><surname>Love-Gregory</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Kacprowski</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Schick</surname>, <given-names>U.M.</given-names></string-name>, <string-name><surname>Nomura</surname>, <given-names>A.</given-names></string-name>, <etal>et al.</etal> (<year>2016</year>). <article-title>Exome Genotyping Identifies Pleiotropic Variants Associated with Red Blood Cell Traits</article-title>. <source>Ajhg</source> <volume>99</volume>, <fpage>8</fpage>&#x2013;<lpage>21</lpage>.</mixed-citation></ref>
<ref id="c8"><mixed-citation publication-type="journal"><string-name><surname>Compston</surname>, <given-names>A.</given-names></string-name>, and <string-name><surname>Coles</surname>, <given-names>A.</given-names></string-name> (<year>2008</year>). <article-title>Multiple sclerosis</article-title>. <source>Lancet</source> <volume>372</volume>, <fpage>1502</fpage>&#x2013;<lpage>1517</lpage>.</mixed-citation></ref>
<ref id="c9"><mixed-citation publication-type="journal"><string-name><surname>Constant</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Pfeiffer</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Woodard</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Pasqualini</surname>, <given-names>T.</given-names></string-name>, and <string-name><surname>Bottomly</surname>, <given-names>K.</given-names></string-name> (<year>1995</year>). <article-title>Extent of T cell receptor ligation can determine the functional differentiation of naive CD4&#x002B; T cells</article-title>. <source>J. Exp. Med</source>. <volume>182</volume>, <fpage>1591</fpage>&#x2013;<lpage>1596</lpage>.</mixed-citation></ref>
<ref id="c10"><mixed-citation publication-type="journal"><string-name><surname>Dankowski</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Buck</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Andlauer</surname>, <given-names>T.F.M.</given-names></string-name>, <string-name><surname>Antony</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Bayas</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Bechmann</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Berthele</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Bettecken</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Chan</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Franke</surname>, <given-names>A.</given-names></string-name>, <etal>et al.</etal> (<year>2015</year>). <article-title>Successful Replication of GWAS Hits for Multiple Sclerosis in 10,000 Germans Using the Exome Array</article-title>. <source>Genet. Epidemiol</source>. <volume>39</volume>, <fpage>601</fpage>&#x2013;<lpage>608</lpage>.</mixed-citation></ref>
<ref id="c11"><mixed-citation publication-type="journal"><string-name><surname>de Jager</surname>, <given-names>P.L.</given-names></string-name>, <string-name><surname>Jia</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>de Bakker</surname>, <given-names>P.I.W.</given-names></string-name>, <string-name><surname>Ottoboni</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Aggarwal</surname>, <given-names>N.T.</given-names></string-name>, <string-name><surname>Piccio</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Raychaudhuri</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Tran</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Aubin</surname>, <given-names>C.</given-names></string-name>, <etal>et al.</etal> (<year>2009</year>). <article-title>Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci</article-title>. <source>Nature Genetics</source> <volume>41</volume>, <fpage>776</fpage>&#x2013;<lpage>782</lpage>.</mixed-citation></ref>
<ref id="c12"><mixed-citation publication-type="journal"><string-name><surname>Dominguez-Villar</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Baecher-Allan</surname>, <given-names>C.M.</given-names></string-name>, and <string-name><surname>Hafler</surname>, <given-names>D.A.</given-names></string-name> (<year>2011</year>). <article-title>Identification of T helper type 1- like, Foxp3&#x002B; regulatory T cells in human autoimmune disease</article-title>. <source>Nature Medicine</source> <volume>17</volume>, <fpage>673</fpage>&#x2013;<lpage>675</lpage>.</mixed-citation></ref>
<ref id="c13"><mixed-citation publication-type="journal"><string-name><surname>Fuchsberger</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Flannick</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Teslovich</surname>, <given-names>T.M.</given-names></string-name>, <string-name><surname>Mahajan</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Agarwala</surname>, <given-names>V.</given-names></string-name>, <string-name><surname>Gaulton</surname>, <given-names>K.J.</given-names></string-name>, <string-name><surname>Ma</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Fontanillas</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Moutsianas</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>McCarthy</surname>, <given-names>D.J.</given-names></string-name>, <etal>et al.</etal> (<year>2016</year>). <article-title>The genetic architecture of type 2 diabetes</article-title>. <source>Nature</source> <volume>536</volume>, <fpage>41</fpage>&#x2013;<lpage>47</lpage>.</mixed-citation></ref>
<ref id="c14"><mixed-citation publication-type="journal"><string-name><surname>House</surname>, <given-names>I.G.</given-names></string-name>, <string-name><surname>Thia</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Brennan</surname>, <given-names>A.J.</given-names></string-name>, <string-name><surname>Tothill</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Dobrovic</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Yeh</surname>, <given-names>W.Z.</given-names></string-name>, <string-name><surname>Saffery</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Chatterton</surname>, <given-names>Z.</given-names></string-name>, <string-name><surname>Trapani</surname>, <given-names>J.A.</given-names></string-name>, and <string-name><surname>Voskoboinik</surname>, <given-names>I.</given-names></string-name> (<year>2015</year>). <article-title>Heterozygosity for the common perforin mutation, p.A91V, impairs the cytotoxicity of primary natural killer cells from healthy individuals. Immunol</article-title>. <source>Cell Biol</source>. <volume>93</volume>, <fpage>575</fpage>&#x2013;<lpage>580</lpage>.</mixed-citation></ref>
<ref id="c15"><mixed-citation publication-type="journal"><string-name><surname>Housley</surname>, <given-names>W.J.</given-names></string-name>, <string-name><surname>Fernandez</surname>, <given-names>S.D.</given-names></string-name>, <string-name><surname>Vera</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Murikinati</surname>, <given-names>S.R.</given-names></string-name>, <string-name><surname>Grutzendler</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Cuerdon</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Glick</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>De Jager</surname>, <given-names>P.L.</given-names></string-name>, <string-name><surname>Mitrovic</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Cotsapas</surname>, <given-names>C.</given-names></string-name>, <etal>et al.</etal> (<year>2015</year>). <article-title>Genetic variants associated with autoimmunity drive NF&#x03BA;B signaling and responses to inflammatory stimuli</article-title>. <source>Science Translational Medicine</source> <volume>7</volume>, <fpage>291</fpage>&#x2013;<lpage>293</lpage>.</mixed-citation></ref>
<ref id="c16"><mixed-citation publication-type="journal"><collab>International Multiple Sclerosis Genetics Consortium</collab> (<year>2013</year>). <article-title>Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis</article-title>. <source>Nature Genetics</source> <volume>45</volume>, <fpage>1353</fpage>&#x2013;<lpage>1360</lpage>.</mixed-citation></ref>
<ref id="c17"><mixed-citation publication-type="journal"><collab>International Multiple Sclerosis Genetics Consortium &#x0026; Wellcome Trust Case Control Consortium 2</collab> (<year>2011</year>). <article-title>Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis</article-title>. <source>Nature</source> <volume>476</volume>, <fpage>214</fpage>&#x2013;<lpage>219</lpage>.</mixed-citation></ref>
<ref id="c18"><mixed-citation publication-type="journal"><string-name><surname>Jakkula</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Lepp&#x00E4;</surname>, <given-names>V.</given-names></string-name>, <string-name><surname>Sulonen</surname>, <given-names>A.-M.</given-names></string-name>, <string-name><surname>Varilo</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Kallio</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Kemppinen</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Purcell</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Koivisto</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Tienari</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Sumelahti</surname>, <given-names>M.-L.</given-names></string-name>, <etal>et al.</etal> (<year>2010</year>). <article-title>Genome-wide association study in a high-risk isolate for multiple sclerosis reveals associated variants in STAT3 gene</article-title>. <source>Am. J. Hum. Genet</source>. <volume>86</volume>, <fpage>285</fpage>&#x2013;<lpage>291</lpage>.</mixed-citation></ref>
<ref id="c19"><mixed-citation publication-type="journal"><string-name><surname>Li</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Samanta</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Song</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Iacono</surname>, <given-names>K.T.</given-names></string-name>, <string-name><surname>Bembas</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Tao</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Basu</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Riley</surname>, <given-names>J.L.</given-names></string-name>, <string-name><surname>Hancock</surname>, <given-names>W.W.</given-names></string-name>, <string-name><surname>Shen</surname>, <given-names>Y.</given-names></string-name>, <etal>et al.</etal> (<year>2007</year>). <article-title>FOXP3 interactions with histone acetyltransferase and class II histone deacetylases are required for repression</article-title>. <source>Proceedings of the National Academy of Sciences</source> <volume>104</volume>, <fpage>4571</fpage>&#x2013;<lpage>4576</lpage>.</mixed-citation></ref>
<ref id="c20"><mixed-citation publication-type="journal"><string-name><surname>Liu</surname>, <given-names>D.J.</given-names></string-name>, <string-name><surname>Peloso</surname>, <given-names>G.M.</given-names></string-name>, <string-name><surname>Yu</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Butterworth</surname>, <given-names>A.S.</given-names></string-name>, <string-name><surname>Wang</surname>, <given-names>X.</given-names></string-name>, <string-name><surname>Mahajan</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Saleheen</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Emdin</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Alam</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Alves</surname>, <given-names>A.C.</given-names></string-name>, <etal>et al.</etal> (<year>2017</year>). <article-title>Exome-wide association study of plasma lipids in &#x003E;300,000 individuals</article-title>. <source>Nature Genetics</source> <volume>49</volume>, <fpage>1758</fpage>&#x2013;<lpage>1766</lpage>.</mixed-citation></ref>
<ref id="c21"><mixed-citation publication-type="journal"><string-name><surname>Manolio</surname>, <given-names>T.A.</given-names></string-name>, <string-name><surname>Collins</surname>, <given-names>F.S.</given-names></string-name>, <string-name><surname>Cox</surname>, <given-names>N.J.</given-names></string-name>, <string-name><surname>Goldstein</surname>, <given-names>D.B.</given-names></string-name>, <string-name><surname>Hindorff</surname>, <given-names>L.A.</given-names></string-name>, <string-name><surname>Hunter</surname>, <given-names>D.J.</given-names></string-name>, <string-name><surname>McCarthy</surname>, <given-names>M.I.</given-names></string-name>, <string-name><surname>Ramos</surname>, <given-names>E.M.</given-names></string-name>, <string-name><surname>Cardon</surname>, <given-names>L.R.</given-names></string-name>, <string-name><surname>Chakravarti</surname>, <given-names>A.</given-names></string-name>, <etal>et al.</etal> (<year>2009</year>). <article-title>Finding the missing heritability of complex diseases</article-title>. <source>Nature</source> <volume>461</volume>, <fpage>747</fpage>&#x2013;<lpage>753</lpage>.</mixed-citation></ref>
<ref id="c22"><mixed-citation publication-type="journal"><string-name><surname>Marouli</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Graff</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Medina-Gomez</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Lo</surname>, <given-names>K.S.</given-names></string-name>, <string-name><surname>Wood</surname>, <given-names>A.R.</given-names></string-name>, <string-name><surname>Kjaer</surname>, <given-names>T.R.</given-names></string-name>, <string-name><surname>Fine</surname>, <given-names>R.S.</given-names></string-name>, <string-name><surname>Lu</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Schurmann</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Highland</surname>, <given-names>H.M.</given-names></string-name>, <etal>et al.</etal> (<year>2017</year>). <article-title>Rare and low-frequency coding variants alter human adult height</article-title>. <source>Nature</source> <volume>542</volume>, <fpage>186</fpage>&#x2013;<lpage>190</lpage>.</mixed-citation></ref>
<ref id="c23"><mixed-citation publication-type="journal"><string-name><surname>Martinelli-Boneschi</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Esposito</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Brambilla</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Lindstr&#x00F6;m</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Lavorgna</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Stankovich</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Rodegher</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Capra</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Ghezzi</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Coniglio</surname>, <given-names>G.</given-names></string-name>, <etal>et al.</etal> (<year>2012</year>). <article-title>A genome-wide association study in progressive multiple sclerosis</article-title>. <source>Multiple Sclerosis Journal</source> <volume>18</volume>, <fpage>1384</fpage>&#x2013;<lpage>1394</lpage>.</mixed-citation></ref>
<ref id="c24"><mixed-citation publication-type="journal"><string-name><surname>Moutsianas</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Jostins</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Beecham</surname>, <given-names>A.H.</given-names></string-name>, <string-name><surname>Dilthey</surname>, <given-names>A.T.</given-names></string-name>, <string-name><surname>Xifara</surname>, <given-names>D.K.</given-names></string-name>, <string-name><surname>Ban</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Shah</surname>, <given-names>T.S.</given-names></string-name>, <string-name><surname>Patsopoulos</surname>, <given-names>N.A.</given-names></string-name>, <string-name><surname>Alfredsson</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Anderson</surname>, <given-names>C.A.</given-names></string-name>, <etal>et al.</etal> (<year>2015</year>). <article-title>Class II HLA interactions modulate genetic risk for multiple sclerosis</article-title>. <source>Nature Genetics</source> <volume>47</volume>, <fpage>1107</fpage>&#x2013;<lpage>1113</lpage>.</mixed-citation></ref>
<ref id="c25"><mixed-citation publication-type="journal"><string-name><surname>Nelson</surname>, <given-names>M.R.</given-names></string-name>, <string-name><surname>Wegmann</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Ehm</surname>, <given-names>M.G.</given-names></string-name>, <string-name><surname>Kessner</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>St Jean</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Verzilli</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Shen</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Tang</surname>, <given-names>Z.</given-names></string-name>, <string-name><surname>Bacanu</surname>, <given-names>S.-A.</given-names></string-name>, <string-name><surname>Fraser</surname>, <given-names>D.</given-names></string-name>, <etal>et al.</etal> (<year>2012</year>). <article-title>An abundance of rare functional variants in 202 drug target genes sequenced in 14,002 people</article-title>. <source>Science</source> <volume>337</volume>, <fpage>100</fpage>&#x2013;<lpage>104</lpage>.</mixed-citation></ref>
<ref id="c26"><mixed-citation publication-type="journal"><string-name><surname>Nischwitz</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Cepok</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Kroner</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Wolf</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Knop</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>M&#x00FC;ller-Sarnowski</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Pfister</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Roeske</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Rieckmann</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Hemmer</surname>, <given-names>B.</given-names></string-name>, <etal>et al.</etal> (<year>2010</year>). <article-title>Evidence for VAV2 and ZNF433 as susceptibility genes for multiple sclerosis</article-title>. <source>Journal of Neuroimmunology</source> <volume>227</volume>, <fpage>162</fpage>&#x2013;<lpage>166</lpage>.</mixed-citation></ref>
<ref id="c27"><mixed-citation publication-type="journal"><string-name><surname>Patsopoulos</surname>, <given-names>N.A.</given-names></string-name>, <collab>the Bayer Pharma MS Genetics Working Group, the Steering Committees of Studies Evaluating IFN&#x03B2;-1b and a CCR1-Antagonist, ANZgene Consortium, Gene MSA, International Multiple Sclerosis Genetics Consortium</collab>, and <string-name><surname>de Bakker</surname>, <given-names>P.I.W.</given-names></string-name> (<year>2011</year>). <article-title>Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci</article-title>. <source>Ann Neurol</source>. <volume>70</volume>, <fpage>897</fpage>&#x2013;<lpage>912</lpage>.</mixed-citation></ref>
<ref id="c28"><mixed-citation publication-type="other"><string-name><surname>Patsopoulos</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Baranzini</surname>, <given-names>S.E.</given-names></string-name>, <string-name><surname>Santaniello</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Shoostari</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Cotsapas</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Wong</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Beecham</surname>, <given-names>A.H.</given-names></string-name>, <string-name><surname>James</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Replogle</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Vlachos</surname>, <given-names>I.</given-names></string-name>, <etal>et al.</etal> (<year>2017</year>). <article-title>The Multiple Sclerosis Genomic Map: Role of peripheral immune cells and resident microglia in susceptibility</article-title>. <source>bioRxiv</source> <fpage>143933</fpage>.</mixed-citation></ref>
<ref id="c29"><mixed-citation publication-type="journal"><string-name><surname>Purcell</surname>, <given-names>S.M.</given-names></string-name>, <string-name><surname>Moran</surname>, <given-names>J.L.</given-names></string-name>, <string-name><surname>Fromer</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Ruderfer</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Solovieff</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Roussos</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>O&#x2019;Dushlaine</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Chambert</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Bergen</surname>, <given-names>S.E.</given-names></string-name>, <string-name><surname>K&#x00E4;hler</surname>, <given-names>A.</given-names></string-name>, <etal>et al.</etal> (<year>2015</year>). <article-title>A polygenic burden of rare disruptive mutations in schizophrenia</article-title>. <source>Nature</source> <volume>506</volume>, <fpage>185</fpage>&#x2013;<lpage>190</lpage>.</mixed-citation></ref>
<ref id="c30"><mixed-citation publication-type="journal"><string-name><surname>Sadler</surname>, <given-names>A.J.</given-names></string-name>, and <string-name><surname>Williams</surname>, <given-names>B.R.G.</given-names></string-name> (<year>2008</year>). <article-title>Interferon-inducible antiviral effectors</article-title>. <source>Nat Rev Immunol</source> <volume>8</volume>, <fpage>559</fpage>&#x2013;<lpage>568</lpage>.</mixed-citation></ref>
<ref id="c31"><mixed-citation publication-type="journal"><string-name><surname>Sanna</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Pitzalis</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Zoledziewska</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Zara</surname>, <given-names>I.</given-names></string-name>, <string-name><surname>Sidore</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Murru</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Whalen</surname>, <given-names>M.B.</given-names></string-name>, <string-name><surname>Busonero</surname>, <given-names>F.</given-names></string-name>, <string-name><surname>Maschio</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Costa</surname>, <given-names>G.</given-names></string-name>, <etal>et al.</etal> (<year>2010</year>). <article-title>Variants within the immunoregulatory CBLB gene are associated with multiple sclerosis</article-title>. <source>Nature Genetics</source> <volume>42</volume>, <fpage>495</fpage>&#x2013;<lpage>497</lpage>.</mixed-citation></ref>
<ref id="c32"><mixed-citation publication-type="journal"><string-name><surname>Sawcer</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Ban</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Maranian</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Yeo</surname>, <given-names>T.W.</given-names></string-name>, <string-name><surname>Compston</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Kirby</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Daly</surname>, <given-names>M.J.</given-names></string-name>, <string-name><surname>de Jager</surname>, <given-names>P.L.</given-names></string-name>, <string-name><surname>Walsh</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Lander</surname>, <given-names>E.S.</given-names></string-name>, <etal>et al.</etal> (<year>2005</year>). <article-title>A high-density screen for linkage in multiple sclerosis</article-title>. <source>Ajhg</source> <volume>77</volume>, <fpage>454</fpage>&#x2013;<lpage>467</lpage>.</mixed-citation></ref>
<ref id="c33"><mixed-citation publication-type="journal"><string-name><surname>Sawcer</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Franklin</surname>, <given-names>R.J.M.</given-names></string-name>, and <string-name><surname>Ban</surname>, <given-names>M.</given-names></string-name> (<year>2014</year>). <article-title>Multiple sclerosis genetics</article-title>. <source>The Lancet Neurology</source> <volume>13</volume>, <fpage>700</fpage>&#x2013;<lpage>709</lpage>.</mixed-citation></ref>
<ref id="c34"><mixed-citation publication-type="other"><string-name><surname>Schoech</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Jordan</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Loh</surname>, <given-names>P.-R.</given-names></string-name>, <string-name><surname>Gazal</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>O&#x2019;Connor</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Balick</surname>, <given-names>D.J.</given-names></string-name>, <string-name><surname>Palamara</surname>, <given-names>P.F.</given-names></string-name>, <string-name><surname>Finucane</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Sunyaev</surname>, <given-names>S.R.</given-names></string-name>, and <string-name><surname>Price</surname>, <given-names>A.L.</given-names></string-name> (<year>2017</year>). <article-title>Quantification of frequency-dependent genetic architectures and action of negative selection in 25 UK Biobank traits</article-title>. <source>bioRxiv</source> <fpage>188086</fpage>.</mixed-citation></ref>
<ref id="c35"><mixed-citation publication-type="journal"><string-name><surname>Sims</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>van der Lee</surname>, <given-names>S.J.</given-names></string-name>, <string-name><surname>Naj</surname>, <given-names>A.C.</given-names></string-name>, <string-name><surname>Bellenguez</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Badarinarayan</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Jakobsdottir</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Kunkle</surname>, <given-names>B.W.</given-names></string-name>, <string-name><surname>Boland</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Raybould</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Bis</surname>, <given-names>J.C.</given-names></string-name>, <etal>et al.</etal> (<year>2017</year>). <article-title>Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer&#x2019;s disease</article-title>. <source>Nature Genetics</source> <volume>49</volume>, <fpage>1373</fpage>&#x2013;<lpage>1384</lpage>.</mixed-citation></ref>
<ref id="c36"><mixed-citation publication-type="journal"><collab>The CHARGE Consortium Hematology Working Group</collab> (<year>2016</year>). <article-title>Meta-analysis of rare and common exome chip variants identifies S1PR4 and other loci influencing blood cell traits</article-title>. <source>Nature Genetics</source> <volume>48</volume>, <fpage>867</fpage>&#x2013;<lpage>876</lpage>.</mixed-citation></ref>
<ref id="c37"><mixed-citation publication-type="journal"><collab>Wellcome Trust Case Control Consortium</collab> (<year>2007</year>). <article-title>Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants</article-title>. <source>Nature Genetics</source> <volume>39</volume>, <fpage>1329</fpage>&#x2013;<lpage>1337</lpage>.</mixed-citation></ref>
<ref id="c38"><mixed-citation publication-type="journal"><string-name><surname>Westerlind</surname>, <given-names>H.</given-names></string-name>, <string-name><surname>Ramanujam</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Uvehag</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Kuja-Halkola</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Boman</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Bottai</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Lichtenstein</surname>, <given-names>P.</given-names></string-name>, and <string-name><surname>Hillert</surname>, <given-names>J.</given-names></string-name> (<year>2014</year>). <article-title>Modest familial risks for multiple sclerosis: a registry-based study of the population of Sweden</article-title>. <source>Brain</source> <volume>137</volume>, <fpage>770</fpage>&#x2013;<lpage>778</lpage>.</mixed-citation></ref>
<ref id="c39"><mixed-citation publication-type="journal"><string-name><surname>Yang</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Lee</surname>, <given-names>S.H.</given-names></string-name>, <string-name><surname>Goddard</surname>, <given-names>M.E.</given-names></string-name>, and <string-name><surname>Visscher</surname>, <given-names>P.M.</given-names></string-name> (<year>2011</year>). <article-title>GCTA: A Tool for Genome-wide Complex Trait Analysis</article-title>. <source>The American Journal of Human Genetics</source> <volume>88</volume>, <fpage>76</fpage>&#x2013;<lpage>82</lpage>.</mixed-citation></ref>
<ref id="c40"><mixed-citation publication-type="other"><string-name><surname>Zeng</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>de Vlaming</surname>, <given-names>R.</given-names></string-name>, <string-name><surname>Wu</surname>, <given-names>Y.</given-names></string-name>, <string-name><surname>Robinson</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Lloyd-Jones</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Yengo</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Yap</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Xue</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Sidorenko</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>McRae</surname>, <given-names>A.</given-names></string-name>, <etal>et al.</etal> (<year>2017</year>). <article-title>Widespread signatures of negative selection in the genetic architecture of human complex traits</article-title>. <source>bioRxiv</source> <fpage>145755</fpage>.</mixed-citation></ref>
</ref-list>
<sec id="s2">
<title>Methods</title>
<sec id="s2a">
<title>Genotyping, quality control and stratum assignment</title>
<p>We assembled a total of 76,140 samples (36,219 cases, 38,629 controls and 1,292 samples with missing phenotype information) from across the International MS Genetics Consortium (IMSGC; <xref ref-type="table" rid="tblS1">Table S1</xref>). We genotyped these either on the Illumina HumanExome Beadchip (exome chip) or on a previously described custom array (<xref ref-type="bibr" rid="c28">Patsopoulos et al., 2017</xref>) including the exome chip content, both manufactured by Illumina Inc. We called genotypes both with Illumina&#x2019;s default algorithm, gencall, and zCall, specifically developed to call low-frequency variants where all three groups of genotypes may not be observed (<xref ref-type="bibr" rid="c43">Goldstein et al., 2012</xref>).</p>
<p>An overview of our quality control process is shown in <xref rid="figS1" ref-type="fig">Figure S1</xref>; we used plink (<xref ref-type="bibr" rid="c47">Purcell et al., 2007</xref>) for all analyses unless otherwise noted. Briefly, we first excluded samples with low genotyping rate, extreme heterozygosity rate, inconsistent genotypic and recorded sex; we also removed closely related samples, keeping the relative with least missing data. Next, we removed population outliers by calculating genotype principal components using 16,066 common variants in linkage disequilibrium (r<sup>2</sup> &#x003C; 0.1) across the exome. We used EIGENSOFT 6 (<xref ref-type="bibr" rid="c46">Price et al., 2006</xref>) and FlashPCA (<xref ref-type="bibr" rid="c41">Abraham and Inouye, 2014</xref>) for cohorts with more than 10.000 individuals. We next removed variants with &#x003E;3&#x0025; gencall missing data rate for variants with minor allele frequency MAF &#x003E;5&#x0025;, or &#x003E;1&#x0025; zCall missing data rate for variants with MAF &#x003C; 5&#x0025;. We also removed variants out of Hardy-Weinberg equilibrium (p &#x003C; 10<sup>-5</sup>). Next, we removed samples with high similarity in missing genotypes (&#x201C;identity by missingness&#x201D;) indicative of production artefact, and samples with missing phenotype information. Finally, we again removed any remaining population outliers using projection principal component analysis. We calculated 30 principal components for 1,092 individuals in 1,000 Genomes reference populations, again using the 16,066 common variants in linkage disequilibrium (r<sup>2</sup> &#x003C; 0.1) across the exome. We then projected the IMSGC samples into this space and excluded individuals more than six standard deviations from loading means as previously described (<xref ref-type="bibr" rid="c46">Price et al., 2006</xref>). We performed the projection and outlier detection and removal steps a total ten times to gradually remove more subtle population outliers.</p>
<p>We compiled cases and controls into strata for analysis as shown in <xref ref-type="table" rid="tblS2">Table S2</xref>. In total, we removed 17,951/76,140 (24&#x0025;) samples either due to low data quality or as population outliers, leaving a final dataset of 27,891 cases and 30,298 controls in 13 strata (<xref rid="figS1" ref-type="fig">Figure S1</xref> and <xref ref-type="table" rid="tblS1">Tables S1</xref> and <xref ref-type="table" rid="tblS2">S2</xref>). Separately, we included summary statistics from 4,476 MS cases and 5,714 controls from Germany, genotyped on the exome chip as previously described (<xref ref-type="bibr" rid="c10">Dankowski et al., 2015</xref>), giving us a total of 32,367 MS cases and 36,012 controls for analysis.</p>
</sec>
<sec id="s2b">
<title>Exome chip coverage of ExAC variants</title>
<p>To assess how thoroughly the exome chip assesses low-frequency coding variation genome-wide, we compared it to the list of variants reported by the Exome Aggregation Consortium, ExAC (<xref ref-type="bibr" rid="c44">Lek et al., 2016</xref>), in their data release version 1. We filtered their summary table of all ExAC variants (available at <ext-link ext-link-type="uri" xlink:href="ftp://ftp.broadinstitute.org/pub/ExAC_release/release1/manuscript_data/ExAC.r1.sites.vep.table.gz">ftp://ftp.broadinstitute.org/pub/ExAC_release/release1/manuscript_data/ExAC.r1.sites.vep.table.gz</ext-link> and last accessed 15 November 2017) for nonsynonymous coding variants passing their quality control, with at least one minor allele observed in non-Finnish European samples. We identified which of these variants are represented on the exome chip by comparing genomic coordinates (<xref rid="figS2" ref-type="fig">Figure S2</xref>).</p>
</sec>
<sec id="s2c">
<title>Univariate association analysis</title>
<p>We used mixed linear models for association analysis, as implemented in GCTA (<xref ref-type="bibr" rid="c39">Yang et al., 2011</xref>). In each of our 13 genotype-level strata, we calculated genetic relatedness matrices from 16,066 common, noncoding variants (overall MAF &#x003E; 0.05) in linkage equilibrium (all pairwise r<sup>2</sup> &#x003C; 0.1) present on the exome chip, and with these calculated univariate association statistics for each autosomal variant present on the exome chip. To further control for population stratification, we also calculated genotypic principal components with the 16,066 common variants, and included these as covariates to the association analysis. We also included genotypic sex and chip type as covariates. We combined statistics across strata using inverse-variance-weighted meta-analysis, also as implemented in GCTA (<xref ref-type="bibr" rid="c39">Yang et al., 2011</xref>). As the bulk of exome chip variants are not common and do not show appreciable linkage disequilibrium, we controlled for multiple tests with a Bonferroni correction for the number of low-frequency variants, to give a genome-wide significance threshold of p &#x003C; 3.58 <italic>&#x00D7;</italic> 10e<sup>-7</sup> (0.05/139,764 variants with a combined MAF &#x003C; 0.05 in controls and a heterogeneity index I<sup>2</sup> &#x003C; 50 in our meta-analysis).</p>
</sec>
<sec id="s2d">
<title>Heritability estimation</title>
<p>We used GCTA to calculate the heritability attributable to groups of variants in each of our 13 genotype-level strata (<xref ref-type="bibr" rid="c39">Yang et al., 2011</xref>). In each stratum, we ran two sets of models: a two-component model, estimating the heritability attributable to common and low-frequency (MAF &#x2264; 0.05) variants; and a three component model with rare (MAF &#x2264; 0.01), intermediate (0.01 &#x003C; MAF &#x2264; 0.05), and common variants. In all strata, common variants are the set of 16,066 independent variants (overall MAF &#x003E; 0.05) used for population stratification calculations in the univariate analysis above. We computed genetic relatedness matrices for each component of each model, then calculated narrow-sense heritability (<italic>h</italic><sup><italic>2</italic></sup>) with 100 iterations of constrained restricted maximum likelihood (REML) fitting, assuming a disease prevalence of 0.001. We also included the principal components of population structure computed for the univariate analysis as covariates. As anticipated, several of the smaller cohorts presented fitting issues: no models converged for FIN; both three-component and two-component fits for UCSF2, and the three-component model for GRE would not converge under constraint and so were run without constraints; and the three-component model for BEL converged on two exactly equally likely solutions after 10,000 iterations. For the latter, we chose the most conservative estimates of variance explained. We combined these estimates with inverse variance-weighted meta-analysis.</p>
</sec>
</sec>
<ref-list>
<title>Methods references</title>
<ref id="c41"><mixed-citation publication-type="journal"><string-name><surname>Abraham</surname>, <given-names>G.</given-names></string-name>, and <string-name><surname>Inouye</surname>, <given-names>M.</given-names></string-name> (<year>2014</year>). <article-title>Fast Principal Component Analysis of Large-Scale Genome-Wide Data</article-title>. <source>PloS One</source> <volume>9</volume>, <fpage>e93766</fpage>.</mixed-citation></ref>
<ref id="c42"><mixed-citation publication-type="journal"><string-name><surname>Dankowski</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Buck</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Andlauer</surname>, <given-names>T.F.M.</given-names></string-name>, <string-name><surname>Antony</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Bayas</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Bechmann</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Berthele</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Bettecken</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Chan</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Franke</surname>, <given-names>A.</given-names></string-name>, <etal>et al.</etal> (<year>2015</year>). <article-title>Successful Replication of GWAS Hits for Multiple Sclerosis in 10,000 Germans Using the Exome Array</article-title>. <source>Genet. Epidemiol</source>. <volume>39</volume>, <fpage>601</fpage>&#x2013;<lpage>608</lpage>.</mixed-citation></ref>
<ref id="c43"><mixed-citation publication-type="journal"><string-name><surname>Goldstein</surname>, <given-names>J.I.</given-names></string-name>, <string-name><surname>Crenshaw</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Carey</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Grant</surname>, <given-names>G.B.</given-names></string-name>, <string-name><surname>Maguire</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Fromer</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>O&#x2019;Dushlaine</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Moran</surname>, <given-names>J.L.</given-names></string-name>, <string-name><surname>Chambert</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Stevens</surname>, <given-names>C.</given-names></string-name>, <etal>et al.</etal> (<year>2012</year>). <article-title>zCall: a rare variant caller for array-based genotyping: Genetics and population analysis</article-title>. <source>Bioinformatics</source> <volume>28</volume>, <fpage>2543</fpage>&#x2013;<lpage>2545</lpage>.</mixed-citation></ref>
<ref id="c44"><mixed-citation publication-type="journal"><string-name><surname>Lek</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Karczewski</surname>, <given-names>K.J.</given-names></string-name>, <string-name><surname>Minikel</surname>, <given-names>E.V.</given-names></string-name>, <string-name><surname>Samocha</surname>, <given-names>K.E.</given-names></string-name>, <string-name><surname>Banks</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Fennell</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>O&#x2019;Donnell-Luria</surname>, <given-names>A.H.</given-names></string-name>, <string-name><surname>Ware</surname>, <given-names>J.S.</given-names></string-name>, <string-name><surname>Hill</surname>, <given-names>A.J.</given-names></string-name>, <string-name><surname>Cummings</surname>, <given-names>B.B.</given-names></string-name>, <etal>et al.</etal> (<year>2016</year>). <article-title>Analysis of protein-coding genetic variation in 60,706 humans</article-title>. <source>Nature</source> <volume>536</volume>, <fpage>285</fpage>&#x2013;<lpage>291</lpage>.</mixed-citation></ref>
<ref id="c45"><mixed-citation publication-type="other"><string-name><surname>Patsopoulos</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Baranzini</surname>, <given-names>S.E.</given-names></string-name>, <string-name><surname>Santaniello</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Shoostari</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Cotsapas</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Wong</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Beecham</surname>, <given-names>A.H.</given-names></string-name>, <string-name><surname>James</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Replogle</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Vlachos</surname>, <given-names>I.</given-names></string-name>, <etal>et al.</etal> (<year>2017</year>). <article-title>The Multiple Sclerosis Genomic Map: Role of peripheral immune cells and resident microglia in susceptibility</article-title>. <source>bioRxiv</source> <fpage>143933</fpage>.</mixed-citation></ref>
<ref id="c46"><mixed-citation publication-type="journal"><string-name><surname>Price</surname>, <given-names>A.L.</given-names></string-name>, <string-name><surname>Patterson</surname>, <given-names>N.J.</given-names></string-name>, <string-name><surname>Plenge</surname>, <given-names>R.M.</given-names></string-name>, <string-name><surname>Weinblatt</surname>, <given-names>M.E.</given-names></string-name>, <string-name><surname>Shadick</surname>, <given-names>N.A.</given-names></string-name>, and <string-name><surname>Reich</surname>, <given-names>D.</given-names></string-name> (<year>2006</year>). <article-title>Principal components analysis corrects for stratification in genome-wide association studies</article-title>. <source>Nature Genetics</source> <volume>38</volume>, <fpage>904</fpage>&#x2013;<lpage>909</lpage>.</mixed-citation></ref>
<ref id="c47"><mixed-citation publication-type="journal"><string-name><surname>Purcell</surname>, <given-names>S.</given-names></string-name>, <string-name><surname>Neale</surname>, <given-names>B.</given-names></string-name>, <string-name><surname>Todd-Brown</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Thomas</surname>, <given-names>L.</given-names></string-name>, <string-name><surname>Ferreira</surname>, <given-names>M.A.R.</given-names></string-name>, <string-name><surname>Bender</surname>, <given-names>D.</given-names></string-name>, <string-name><surname>Maller</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Sklar</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>de Bakker</surname>, <given-names>P.I.W.</given-names></string-name>, <string-name><surname>Daly</surname>, <given-names>M.J.</given-names></string-name>, <etal>et al.</etal> (<year>2007</year>). <article-title>PLINK: a tool set for whole-genome association and population-based linkage analyses</article-title>. <source>Ajhg</source> <volume>81</volume>, <fpage>559</fpage>&#x2013;<lpage>575</lpage>.</mixed-citation></ref>
<ref id="c48"><mixed-citation publication-type="journal"><string-name><surname>Yang</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Lee</surname>, <given-names>S.H.</given-names></string-name>, <string-name><surname>Goddard</surname>, <given-names>M.E.</given-names></string-name>, and <string-name><surname>Visscher</surname>, <given-names>P.M.</given-names></string-name> (<year>2011</year>). <article-title>GCTA: A Tool for Genome-wide Complex Trait Analysis</article-title>. <source>The American Journal of Human Genetics</source> <volume>88</volume>, <fpage>76</fpage>&#x2013;<lpage>82</lpage>.</mixed-citation></ref>
</ref-list>
<sec id="s3">
<title>Supplementary information</title>
<fig id="figS1" position="float" fig-type="figure">
<label>Figure S1</label>
<caption><title>quality control pipeline overview.</title>
<p>We assembled 46 cohorts of data (either entire country-level collections or groups of samples processed as a batch; <xref ref-type="table" rid="tblS1">Table S1</xref>). We called common variant genotypes with the standard algorithm provided by Illumina (GenCall), and low-frequency variants with zCall, an algorithm specifically developed to call these variants on the exome chip (<xref ref-type="bibr" rid="c43">Goldstein et al., 2012</xref>). We performed initial quality control on each cohort separately to account for variation between batches and cohorts (upper gray region), then merged cohorts into 13 country-level strata. To ensure that these strata were uniform we then performed stringent quality control on each stratum (lower gray region) to produce our final dataset.</p></caption>
<graphic xlink:href="286617v1_figS1.tif"/>
</fig>
<fig id="figS2" position="float" fig-type="figure">
<label>Figure S2</label>
<caption><title>the exome chip captures a large fraction of ExAC (release version 1) low-frequency miss-sense variants.</title>
<p>The exome chip captures the majority of variants present in ExAC (<xref ref-type="bibr" rid="c44">Lek et al., 2016</xref>) down to a minor allele frequency &#x223C; 0.0005, below which a large number of variants is observed (upper panel). Thus, the overall coverage at very rare alleles (5 &#x00D7; 10<sup>-4</sup> &#x003E; MAF &#x003E; 1.5 &#x00D7; 10<sup>-5</sup>, corresponding to a single allele seen in 33,370 non-Finnish European individuals in ExAC) is low (lower panel).</p></caption>
<graphic xlink:href="286617v1_figS2.tif"/>
</fig>
<fig id="figS3" position="float" fig-type="figure">
<label>Figure S3</label>
<caption><title>effect size correlates with minor allele frequency.</title>
<p>We conducted a meta-analysis of 144,209 low-frequency coding variants across all autosomal exons, concentrating on non-synonymous variants which are more likely to have a phenotypic effect. We analyzed a total of 32,367 MS cases and 36,012 controls in thirteen strata. Here, we show that effect size (&#x03B2; or log odds ratio, y axis) correlates to allele frequency (number of minor alleles present in control samples, x axis). Because many low-frequency variants are not present in all cohorts, we stratify these data by number of cohorts in which a variant is polymorphic (subplots). Rarer variants have larger estimated effect sizes, and are present in fewer cohorts.</p></caption>
<graphic xlink:href="286617v1_figS3.tif"/>
</fig>
<fig id="figS4" position="float" fig-type="figure">
<label>Figure S4</label>
<caption><title>forest plots for genome-wide significant low-frequency variants.</title>
<p>Seven variants in six genes are significant in our analysis (<italic>p &#x003C; 3.5</italic> &#x00D7; <italic>10</italic><sup><italic>-7</italic></sup>, Bonferroni correction for the total number of variants genotyped). Two of these (<italic>TYK2</italic> p.Pro1104Ala and <italic>GALC</italic> p.Asp84Asp), are in linkage disequilibrium with known GWAS hits. Studies are ordered by increasing sample size.</p></caption>
<graphic xlink:href="286617v1_figS4.tif"/>
</fig>
<table-wrap id="tblS1" orientation="portrait" position="float">
<label>Table S1</label>
<caption><title>genotype-level samples included in our study.</title>
<p>58,189/76,140 (76.5&#x0025;) of our samples passed quality control and could be assigned to one of thirteen strata. 9,473/17,951 (52.8&#x0025;) of failed samples did not pass a heterogeneity versus missing data rate filter, suggesting either poor data quality or population stratification (detailed in <xref rid="figS1" ref-type="fig">Figure S1</xref>). We used two versions of Illumina&#x2019;s HumanCore Exome array: the standard product (version 1.0; designated <italic>Exome_v1.x</italic> in the chip type column) and a customized version including &#x223C;100,000 additional variants we specified (designated <italic>MS_chip</italic>), described elsewhere (<xref ref-type="bibr" rid="c28">Patsopoulos et al., 2017</xref>). Belgian control samples were genotyped at the Center for Inherited Disease Research (CIDR, Baltimore, MD, USA) on the Illumina 5M array (Illumina, San Diego, CA, USA) as part of the Stroke Genetics Network (SiGN).</p></caption>
<graphic xlink:href="286617v1_tblS1.tif"/>
</table-wrap>
<table-wrap id="tblS2" orientation="portrait" position="float">
<label>Table S2</label>
<caption><title>final stratum composition.</title>
<p>We assigned 58,189 samples passing quality control to one of thirteen strata based on demography as described in the methods; data for 10,190 samples from Germany were received as post-QC summary statistics and are not included in <xref ref-type="table" rid="tblS1">Table S1</xref>. This gave us a total of 68,379 samples in our analysis. We had very few Australian control samples and so merged them with samples from the UK.</p></caption>
<graphic xlink:href="286617v1_tblS2.tif"/>
</table-wrap>
</sec>
<ack id="s4">
<title>Acknowledgements</title>
<sec id="s4b">
<title>Australia</title>
<p>Sample collection and genotyping was supported by NHMRC Project Grant APP605511.</p>
</sec>
<sec id="s4c">
<title>Belgium</title>
<p>BD, RL and PVD are Clinical Investigators of the Research Foundation Flanders (FWO-Vlaanderen). AG and BD are supported by the Research Fund KU Leuven (C24/16/045) and the Research Foundation Flanders (FWO-Vlaanderen) (G.0734.15). The SiGN study was funded by a cooperative agreement grant from the US National Institute of Neurological Disorders and Stroke, National Institutes of Health (U01-NS069208).</p>
</sec>
<sec id="s4d">
<title>Italy</title>
<p>Sample collection and genotyping was supported by the Italian Foundation for Multiple Sclerosis (FISM grants, Special Project &#x201C;Immunochip&#x201D; 2011/R/1, 2015/R/10) and Fondazione Cariplo (Grant 2010-0728).</p>
</sec>
<sec id="s4e">
<title>Norway</title>
<p>The Norwegian MS and control samples were collected and funded in collaboration between the Multiple Sclerosis research group in at Oslo University Hospital/University in Oslo, The Norwegian MS Registry and Biobank in Bergen and the Norwegian Bone Marrow Registry, supported by the Oslo MS Association, Bergen MS Society, Odda MS Society and the Research Council of Norway (grant 240102_Harbo).</p>
</sec>
<sec id="s4f">
<title>Sweden</title>
<p>Sample collection and genotyping was supported by the Swedish Medical Research Council; Swedish Research Council for Health, Working Life and Welfare, Knut and Alice Wallenberg Foundation, AFA insurance, Swedish Brain Foundation, the Swedish Association for Persons with Neurological Disabilities, Astra Zeneca Science for Life grant.</p>
</sec>
<sec id="s4g">
<title>UK</title>
<p>This study makes use of data generated as part of the Wellcome Trust Case Control Consortium 2 project (085475/B/08/Z and 085475/Z/08/Z), including data from the British 1958 Birth Cohort DNA collection (funded by the Medical Research Council grant G0000934 and the Wellcome Trust grant 068545/Z/02) and the UK National Blood Service controls (funded by the Wellcome Trust). The study was supported by the Cambridge NIHR Biomedical Research Centre, UK Medical Research Council (G1100125) and the UK MS society (861/07). We thank the National Institute for Health Research and NHS Blood and Transplant. TwinsUK is funded by the Wellcome Trust, Medical Research Council, European Union, the National Institute for Health Research (NIHR)-funded BioResource, Clinical Research Facility and Biomedical Research Centre based at Guy&#x2019;s and St Thomas&#x2019; NHS Foundation Trust in partnership with King&#x2019;s College London. We thank the volunteers from the Oxford Biobank(<ext-link ext-link-type="uri" xlink:href="http://www.oxfordbiobank.org.uk">www.oxfordbiobank.org.uk</ext-link>) for their participation. The recall process was supported by the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre Programme. We gratefully acknowledge the participation of all NIHR Cambridge BioResource volunteers, and thank the NIHR Cambridge BioResource centre and staff for their contribution. We thank the National Institute for Health Research and NHS Blood and Transplant.</p>
</sec>
<sec id="s4h">
<title>USA</title>
<p>We thank the Biorepository Facility and the Center for Genome Technology laboratory personnel (specifically Sandra West, Simone Clarke, Daniela Martinez, and Patrice Whitehead) within the John P. Hussman Institute for Human Genomics at the University of Miami for centralized DNA handling and genotyping for this project. Related funding support: The US National Multiple Sclerosis Society (grants RG-4680-A-1) and the NIH (R01-NS096212, R01-NS049477 and R01-NS026799).</p>
</sec>
</ack>
<ref-list>
<title>Supplementary references</title>
<ref id="c52"><mixed-citation publication-type="journal"><string-name><surname>Goldstein</surname>, <given-names>J.I.</given-names></string-name>, <string-name><surname>Crenshaw</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Carey</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Grant</surname>, <given-names>G.B.</given-names></string-name>, <string-name><surname>Maguire</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Fromer</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>O&#x2019;Dushlaine</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Moran</surname>, <given-names>J.L.</given-names></string-name>, <string-name><surname>Chambert</surname>, <given-names>K.</given-names></string-name>, <string-name><surname>Stevens</surname>, <given-names>C.</given-names></string-name>, <etal>et al.</etal> (<year>2012</year>). <article-title>zCall: a rare variant caller for array-based genotyping: Genetics and population analysis</article-title>. <source>Bioinformatics</source> <volume>28</volume>, <fpage>2543</fpage>&#x2013;<lpage>2545</lpage>.</mixed-citation></ref>
<ref id="c53"><mixed-citation publication-type="journal"><string-name><surname>Lek</surname>, <given-names>M.</given-names></string-name>, <string-name><surname>Karczewski</surname>, <given-names>K.J.</given-names></string-name>, <string-name><surname>Minikel</surname>, <given-names>E.V.</given-names></string-name>, <string-name><surname>Samocha</surname>, <given-names>K.E.</given-names></string-name>, <string-name><surname>Banks</surname>, <given-names>E.</given-names></string-name>, <string-name><surname>Fennell</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>O&#x2019;Donnell-Luria</surname>, <given-names>A.H.</given-names></string-name>, <string-name><surname>Ware</surname>, <given-names>J.S.</given-names></string-name>, <string-name><surname>Hill</surname>, <given-names>A.J.</given-names></string-name>, <string-name><surname>Cummings</surname>, <given-names>B.B.</given-names></string-name>, <etal>et al.</etal> (<year>2016</year>). <article-title>Analysis of protein-coding genetic variation in 60,706 humans</article-title>. <source>Nature</source> <volume>536</volume>, <fpage>285</fpage>&#x2013;<lpage>291</lpage>.</mixed-citation></ref>
<ref id="c54"><mixed-citation publication-type="journal"><string-name><surname>Patsopoulos</surname>, <given-names>N.</given-names></string-name>, <string-name><surname>Baranzini</surname>, <given-names>S.E.</given-names></string-name>, <string-name><surname>Santaniello</surname>, <given-names>A.</given-names></string-name>, <string-name><surname>Shoostari</surname>, <given-names>P.</given-names></string-name>, <string-name><surname>Cotsapas</surname>, <given-names>C.</given-names></string-name>, <string-name><surname>Wong</surname>, <given-names>G.</given-names></string-name>, <string-name><surname>Beecham</surname>, <given-names>A.H.</given-names></string-name>, <string-name><surname>James</surname>, <given-names>T.</given-names></string-name>, <string-name><surname>Replogle</surname>, <given-names>J.</given-names></string-name>, <string-name><surname>Vlachos</surname>, <given-names>I.</given-names></string-name>, <etal>et al.</etal> (<year>2017</year>). <article-title>The Multiple Sclerosis Genomic Map: Role of peripheral immune cells and resident microglia in susceptibility</article-title>. <source>bioRxiv</source> <fpage>143933</fpage>.</mixed-citation></ref>
</ref-list>
</back>
</article>